{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:02:10Z","timestamp":1791446530813,"version":"4.3.3"},"reference-count":427,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Spanish Agencia Estatal de Investigaci\u00f3n, AEI","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Spanish Agencia Estatal de Investigaci\u00f3n, AEI","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Spanish Agencia Estatal de Investigaci\u00f3n, AEI","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Spanish Agencia Estatal de Investigaci\u00f3n, AEI","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Spanish Agencia Estatal de Investigaci\u00f3n, AEI","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Spanish Agencia Estatal de Investigaci\u00f3n, AEI","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Spanish Agencia Estatal de Investigaci\u00f3n, AEI","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Spanish Agencia Estatal de Investigaci\u00f3n, AEI","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Spanish Agencia Estatal de Investigaci\u00f3n, AEI","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Spanish Agencia Estatal de Investigaci\u00f3n, AEI","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Spanish Agencia Estatal de Investigaci\u00f3n, AEI","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Spanish Ministry of Universities","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Spanish Ministry of Universities","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Spanish Ministry of Universities","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Spanish Ministry of Universities","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Spanish Ministry of Universities","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Spanish Ministry of Universities","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Spanish Ministry of Universities","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Spanish Ministry of Universities","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Spanish Ministry of Universities","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Spanish Ministry of Universities","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Spanish Ministry of Universities","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"University of Valladolid","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"University of Valladolid","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"University of Valladolid","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"University of Valladolid","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"University of Valladolid","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"University of Valladolid","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"University of Valladolid","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"University of Valladolid","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"University of Valladolid","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"University of Valladolid","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"University of Valladolid","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC)","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC)","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC)","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC)","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC)","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC)","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC)","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC)","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC)","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC)","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (AECC)","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Ligue contre le Cancer (\u00e9quipe labellis\u00e9e)","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Ligue contre le Cancer (\u00e9quipe labellis\u00e9e)","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Ligue contre le Cancer (\u00e9quipe labellis\u00e9e)","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Ligue contre le Cancer (\u00e9quipe labellis\u00e9e)","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Ligue contre le Cancer (\u00e9quipe labellis\u00e9e)","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Ligue contre le Cancer (\u00e9quipe labellis\u00e9e)","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Ligue contre le Cancer (\u00e9quipe labellis\u00e9e)","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Ligue contre le Cancer (\u00e9quipe labellis\u00e9e)","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Ligue contre le Cancer (\u00e9quipe labellis\u00e9e)","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Ligue contre le Cancer (\u00e9quipe labellis\u00e9e)","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Ligue contre le Cancer (\u00e9quipe labellis\u00e9e)","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Agence National de la Recherche","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Agence National de la Recherche","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Agence National de la Recherche","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Agence National de la Recherche","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Agence National de la Recherche","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Agence National de la Recherche","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Agence National de la Recherche","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Agence National de la Recherche","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Agence National de la Recherche","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Agence National de la Recherche","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Agence National de la Recherche","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Association pour la recherche sur le cancer (ARC)","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Association pour la recherche sur le cancer (ARC)","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Association pour la recherche sur le cancer (ARC)","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Association pour la recherche sur le cancer (ARC)","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Association pour la recherche sur le cancer (ARC)","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Association pour la recherche sur le cancer (ARC)","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Association pour la recherche sur le cancer (ARC)","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Association pour la recherche sur le cancer (ARC)","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Association pour la recherche sur le cancer (ARC)","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Association pour la recherche sur le cancer (ARC)","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Association pour la recherche sur le cancer (ARC)","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Canc\u00e9rop\u00f4le Ile-de-France; Fondation pour la Recherche M\u00e9dicale (FRM)","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Canc\u00e9rop\u00f4le Ile-de-France; Fondation pour la Recherche M\u00e9dicale (FRM)","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Canc\u00e9rop\u00f4le Ile-de-France; Fondation pour la Recherche M\u00e9dicale (FRM)","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Canc\u00e9rop\u00f4le Ile-de-France; Fondation pour la Recherche M\u00e9dicale (FRM)","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Canc\u00e9rop\u00f4le Ile-de-France; Fondation pour la Recherche M\u00e9dicale (FRM)","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Canc\u00e9rop\u00f4le Ile-de-France; Fondation pour la Recherche M\u00e9dicale (FRM)","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Canc\u00e9rop\u00f4le Ile-de-France; Fondation pour la Recherche M\u00e9dicale (FRM)","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Canc\u00e9rop\u00f4le Ile-de-France; Fondation pour la Recherche M\u00e9dicale (FRM)","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Canc\u00e9rop\u00f4le Ile-de-France; Fondation pour la Recherche M\u00e9dicale (FRM)","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Canc\u00e9rop\u00f4le Ile-de-France; Fondation pour la Recherche M\u00e9dicale (FRM)","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Canc\u00e9rop\u00f4le Ile-de-France; Fondation pour la Recherche M\u00e9dicale (FRM)","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Elior","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Elior","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Elior","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Elior","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Elior","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Elior","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Elior","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Elior","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Elior","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Elior","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Elior","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"European Joint Programme on Rare Diseases (EJPRD) Wilsonmed","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"European Joint Programme on Rare Diseases (EJPRD) Wilsonmed","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"European Joint Programme on Rare Diseases (EJPRD) Wilsonmed","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"European Joint Programme on Rare Diseases (EJPRD) Wilsonmed","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"European Joint Programme on Rare Diseases (EJPRD) Wilsonmed","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"European Joint Programme on Rare Diseases (EJPRD) Wilsonmed","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"European Joint Programme on Rare Diseases (EJPRD) Wilsonmed","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"European Joint Programme on Rare Diseases (EJPRD) Wilsonmed","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"European Joint Programme on Rare Diseases (EJPRD) Wilsonmed","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"European Joint Programme on Rare Diseases (EJPRD) Wilsonmed","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"European Joint Programme on Rare Diseases (EJPRD) Wilsonmed","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"European Research Council Advanced Investigator Award","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"European Research Council Advanced Investigator Award","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"European Research Council Advanced Investigator Award","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"European Research Council Advanced Investigator Award","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"European Research Council Advanced Investigator Award","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"European Research Council Advanced Investigator Award","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"European Research Council Advanced Investigator Award","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"European Research Council Advanced Investigator Award","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"European Research Council Advanced Investigator Award","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"European Research Council Advanced Investigator Award","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"European Research Council Advanced Investigator Award","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"ERA4 Health Cardinoff Grant Ener-LIGHT","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"ERA4 Health Cardinoff Grant Ener-LIGHT","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"ERA4 Health Cardinoff Grant Ener-LIGHT","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"ERA4 Health Cardinoff Grant Ener-LIGHT","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"ERA4 Health Cardinoff Grant Ener-LIGHT","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"ERA4 Health Cardinoff Grant Ener-LIGHT","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"ERA4 Health Cardinoff Grant Ener-LIGHT","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"ERA4 Health Cardinoff Grant Ener-LIGHT","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"ERA4 Health Cardinoff Grant Ener-LIGHT","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"ERA4 Health Cardinoff Grant Ener-LIGHT","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"ERA4 Health Cardinoff Grant Ener-LIGHT","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"European Union Horizon 2020 research and innovation programmes Oncobiome","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"European Union Horizon 2020 research and innovation programmes Oncobiome","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"European Union Horizon 2020 research and innovation programmes Oncobiome","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"European Union Horizon 2020 research and innovation programmes Oncobiome","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"European Union Horizon 2020 research and innovation programmes Oncobiome","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"European Union Horizon 2020 research and innovation programmes Oncobiome","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"European Union Horizon 2020 research and innovation programmes Oncobiome","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"European Union Horizon 2020 research and innovation programmes Oncobiome","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"European Union Horizon 2020 research and innovation programmes Oncobiome","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"European Union Horizon 2020 research and innovation programmes Oncobiome","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"European Union Horizon 2020 research and innovation programmes Oncobiome","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Prevalung","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Prevalung","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Prevalung","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Prevalung","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Prevalung","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Prevalung","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Prevalung","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Prevalung","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Prevalung","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Prevalung","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Prevalung","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Neutrocure","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Neutrocure","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Neutrocure","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Neutrocure","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Neutrocure","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Neutrocure","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Neutrocure","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Neutrocure","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Neutrocure","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Neutrocure","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Neutrocure","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Agence Nationale de la Recherche under the France 2030 programme","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Agence Nationale de la Recherche under the France 2030 programme","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Agence Nationale de la Recherche under the France 2030 programme","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Agence Nationale de la Recherche under the France 2030 programme","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Agence Nationale de la Recherche under the France 2030 programme","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Agence Nationale de la Recherche under the France 2030 programme","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Agence Nationale de la Recherche under the France 2030 programme","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Agence Nationale de la Recherche under the France 2030 programme","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Agence Nationale de la Recherche under the France 2030 programme","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Agence Nationale de la Recherche under the France 2030 programme","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Agence Nationale de la Recherche under the France 2030 programme","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Institut National du Cancer (INCa)","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Institut National du Cancer (INCa)","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Institut National du Cancer (INCa)","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Institut National du Cancer (INCa)","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Institut National du Cancer (INCa)","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Institut National du Cancer (INCa)","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Institut National du Cancer (INCa)","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Institut National du Cancer (INCa)","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Institut National du Cancer (INCa)","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Institut National du Cancer (INCa)","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Institut National du Cancer (INCa)","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Institut Universitaire de France","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Institut Universitaire de France","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Institut Universitaire de France","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Institut Universitaire de France","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Institut Universitaire de France","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Institut Universitaire de France","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Institut Universitaire de France","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Institut Universitaire de France","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Institut Universitaire de France","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Institut Universitaire de France","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Institut Universitaire de France","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"LabEx Immuno-Oncology ANR-18-IDEX-0001","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"LabEx Immuno-Oncology ANR-18-IDEX-0001","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"LabEx Immuno-Oncology ANR-18-IDEX-0001","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"LabEx Immuno-Oncology ANR-18-IDEX-0001","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"LabEx Immuno-Oncology ANR-18-IDEX-0001","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"LabEx Immuno-Oncology ANR-18-IDEX-0001","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"LabEx Immuno-Oncology ANR-18-IDEX-0001","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"LabEx Immuno-Oncology ANR-18-IDEX-0001","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"LabEx Immuno-Oncology ANR-18-IDEX-0001","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"LabEx Immuno-Oncology ANR-18-IDEX-0001","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"LabEx Immuno-Oncology ANR-18-IDEX-0001","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Cancer Research ASPIRE Award from the Mark Foundation","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Cancer Research ASPIRE Award from the Mark Foundation","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Cancer Research ASPIRE Award from the Mark Foundation","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Cancer Research ASPIRE Award from the Mark Foundation","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Cancer Research ASPIRE Award from the Mark Foundation","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Cancer Research ASPIRE Award from the Mark Foundation","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Cancer Research ASPIRE Award from the Mark Foundation","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Cancer Research ASPIRE Award from the Mark Foundation","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Cancer Research ASPIRE Award from the Mark Foundation","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Cancer Research ASPIRE Award from the Mark Foundation","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Cancer Research ASPIRE Award from the Mark Foundation","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"PAIR-Ob\u00e9sit\u00e9 INCa_1873, the RHUs Immunolife and LUCA-pi","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"PAIR-Ob\u00e9sit\u00e9 INCa_1873, the RHUs Immunolife and LUCA-pi","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"PAIR-Ob\u00e9sit\u00e9 INCa_1873, the RHUs Immunolife and LUCA-pi","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"PAIR-Ob\u00e9sit\u00e9 INCa_1873, the RHUs Immunolife and LUCA-pi","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"PAIR-Ob\u00e9sit\u00e9 INCa_1873, the RHUs Immunolife and LUCA-pi","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"PAIR-Ob\u00e9sit\u00e9 INCa_1873, the RHUs Immunolife and LUCA-pi","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"PAIR-Ob\u00e9sit\u00e9 INCa_1873, the RHUs Immunolife and LUCA-pi","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"PAIR-Ob\u00e9sit\u00e9 INCa_1873, the RHUs Immunolife and LUCA-pi","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"PAIR-Ob\u00e9sit\u00e9 INCa_1873, the RHUs Immunolife and LUCA-pi","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"PAIR-Ob\u00e9sit\u00e9 INCa_1873, the RHUs Immunolife and LUCA-pi","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"PAIR-Ob\u00e9sit\u00e9 INCa_1873, the RHUs Immunolife and LUCA-pi","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Seerave Foundation","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Seerave Foundation","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Seerave Foundation","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Seerave Foundation","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Seerave Foundation","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Seerave Foundation","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Seerave Foundation","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Seerave Foundation","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Seerave Foundation","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Seerave Foundation","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Seerave Foundation","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"Institut National du Cancer, Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"Institut National du Cancer, Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"Institut National du Cancer, Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"Institut National du Cancer, Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"Institut National du Cancer, Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"Institut National du Cancer, Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"Institut National du Cancer, Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"Institut National du Cancer, Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"Institut National du Cancer, Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"Institut National du Cancer, Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"Institut National du Cancer, Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]},{"name":"INSERM","award":["PID2021-126426OB-I00"],"award-info":[{"award-number":["PID2021-126426OB-I00"]}]},{"name":"INSERM","award":["ANR-22-CE14-0066 VIVORUSH"],"award-info":[{"award-number":["ANR-22-CE14-0066 VIVORUSH"]}]},{"name":"INSERM","award":["ANR-23-CE44-0030 COPPERMAC"],"award-info":[{"award-number":["ANR-23-CE44-0030 COPPERMAC"]}]},{"name":"INSERM","award":["ANR-23-R4HC-0006 En-er-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 En-er-LIGHT"]}]},{"name":"INSERM","award":["101052444"],"award-info":[{"award-number":["101052444"]}]},{"name":"INSERM","award":["825410"],"award-info":[{"award-number":["825410"]}]},{"name":"INSERM","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"name":"INSERM","award":["861878"],"award-info":[{"award-number":["861878"]}]},{"name":"INSERM","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"INSERM","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}]},{"name":"INSERM","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Colorectal cancer (CRC) affects approximately 2 million people worldwide. Obesity is the major risk factor for CRC. In addition, obesity contributes to a chronic inflammatory stage that enhances tumor progression through the secretion of proinflammatory cytokines. In addition to an increased inflammatory response, obesity-associated cancer presents accrued molecular factors related to cancer characteristics, such as genome instability, sustained cell proliferation, telomere dysfunctions, angiogenesis, and microbial alteration, among others. Despite the evidence accumulated over the last few years, the treatments for obesity-associated CRC do not differ from the CRC treatments in normal-weight individuals. In this review, we summarize the current knowledge on obesity-associated cancer, including its epidemiology, risk factors, molecular factors, and current treatments. Finally, we enumerate possible new therapeutic targets that may improve the conditions of obese CRC patients. Obesity is key for the development of CRC, and treatments resulting in the reversal of obesity should be considered as a strategy for improving antineoplastic CRC therapies.<\/jats:p>","DOI":"10.3390\/ijms25168836","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:23:27Z","timestamp":1723613007000},"page":"8836","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Obesity-Associated Colorectal Cancer"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8807-7920","authenticated-orcid":false,"given":"Lucia","family":"Gonzalez-Gutierrez","sequence":"first","affiliation":[{"name":"Unidad de Excelencia Instituto de Biolog\u00eda y Gen\u00e9tica Molecular (IBGM), Universidad de Valladolid\u2013CSIC, 47003 Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3858-0966","authenticated-orcid":false,"given":"Omar","family":"Moti\u00f1o","sequence":"additional","affiliation":[{"name":"Unidad de Excelencia Instituto de Biolog\u00eda y Gen\u00e9tica Molecular (IBGM), Universidad de Valladolid\u2013CSIC, 47003 Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7443-8337","authenticated-orcid":false,"given":"Daniel","family":"Barriuso","sequence":"additional","affiliation":[{"name":"Unidad de Excelencia Instituto de Biolog\u00eda y Gen\u00e9tica Molecular (IBGM), Universidad de Valladolid\u2013CSIC, 47003 Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0355-0250","authenticated-orcid":false,"given":"Juan","family":"de la Puente-Aldea","sequence":"additional","affiliation":[{"name":"Unidad de Excelencia Instituto de Biolog\u00eda y Gen\u00e9tica Molecular (IBGM), Universidad de Valladolid\u2013CSIC, 47003 Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5663-3518","authenticated-orcid":false,"given":"Lucia","family":"Alvarez-Frutos","sequence":"additional","affiliation":[{"name":"Unidad de Excelencia Instituto de Biolog\u00eda y Gen\u00e9tica Molecular (IBGM), Universidad de Valladolid\u2013CSIC, 47003 Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-4405","authenticated-orcid":false,"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[{"name":"Centre de Recherche des Cordeliers, Equipe Labellis\u00e9e par la Ligue Contre le Cancer, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Inserm U1138, Institut Universitaire de France, 75006 Paris, France"},{"name":"Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France"},{"name":"Institut du Cancer Paris CARPEM, Department of Biology, H\u00f4pital Europ\u00e9en Georges Pompidou, AP-HP, 75015 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0867-1277","authenticated-orcid":false,"given":"Roberto","family":"Palacios-Ramirez","sequence":"additional","affiliation":[{"name":"Unidad de Excelencia Instituto de Biolog\u00eda y Gen\u00e9tica Molecular (IBGM), Universidad de Valladolid\u2013CSIC, 47003 Valladolid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6887-2436","authenticated-orcid":false,"given":"Laura","family":"Senovilla","sequence":"additional","affiliation":[{"name":"Unidad de Excelencia Instituto de Biolog\u00eda y Gen\u00e9tica Molecular (IBGM), Universidad de Valladolid\u2013CSIC, 47003 Valladolid, Spain"},{"name":"Centre de Recherche des Cordeliers, Equipe Labellis\u00e9e par la Ligue Contre le Cancer, Universit\u00e9 Paris Cit\u00e9, Sorbonne Universit\u00e9, Inserm U1138, Institut Universitaire de France, 75006 Paris, France"},{"name":"Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, 94805 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3322\/caac.21395","article-title":"Colorectal cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41575-019-0253-4","article-title":"Early-onset colorectal cancer: Initial clues and current views","volume":"17","author":"Hofseth","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Atchade, A.M., Williams, J.L., Mermelstein, L., and Nemesure, B. (2024). Unraveling the complexities of early-onset colorectal cancer: A perspective on dietary and microbial influences. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1370108"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1053\/j.gastro.2017.02.015","article-title":"Dietary patterns and risk of colorectal cancer: Analysis by tumor location and molecular subtypes","volume":"152","author":"Mehta","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/gutjnl-2013-304701","article-title":"Obesity and colorectal cancer","volume":"62","author":"Bardou","year":"2013","journal-title":"Gut"},{"key":"ref_8","unstructured":"(2024, March 01). Available online: https:\/\/www.who.int\/es\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: A systematic analysis for the global burden of disease study 2019","volume":"396","author":"Collaborators","year":"2020","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/aje\/kwn401","article-title":"Association between body mass index and colorectal neoplasia at follow-up colonoscopy: A pooling study","volume":"169","author":"Jacobs","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Seo, J.Y., Jin, E.H., Chung, G.E., Kim, Y.S., Bae, J.H., Yim, J.Y., Han, K.D., and Yang, S.Y. (2023). The risk of colorectal cancer according to obesity status at four-year intervals: A nationwide population-based cohort study. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-36111-6"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wilson, R.B., Lathigara, D., and Kaushal, D. (2023). Systematic review and meta-analysis of the impact of bariatric surgery on future cancer risk. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076192"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.4240\/wjgs.v15.i10.2331","article-title":"Bariatric surgery reduces colorectal cancer incidence in obese individuals: Systematic review and meta-analysis","volume":"15","author":"Liu","year":"2023","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chierici, A., Amoretti, P., Drai, C., De Fatico, S., Barriere, J., Schiavo, L., and Iannelli, A. (2023). Does bariatric surgery reduce the risk of colorectal cancer in individuals with morbid obesity? A systematic review and meta-analysis. Nutrients, 15.","DOI":"10.3390\/nu15020467"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/1097-0142(19930801)72:3+<962::AID-CNCR2820721303>3.0.CO;2-H","article-title":"The molecular biology of carcinogenesis","volume":"72","author":"Pitot","year":"1993","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Morgado-Diaz, J.A. (2022). Colorectal cancer: An overview. Gastrointestinal Cancers, Exon Publications.","DOI":"10.36255\/exon-publications-gastrointestinal-cancers"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.3748\/wjg.v21.i17.5167","article-title":"Sex- and gender-specific disparities in colorectal cancer risk","volume":"21","author":"Kim","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Roshandel, G., Ghasemi-Kebria, F., and Malekzadeh, R. (2024). Colorectal cancer: Epidemiology, risk factors, and prevention. Cancers, 16.","DOI":"10.3390\/cancers16081530"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/jgh.15364","article-title":"Increasing changes in visceral adiposity is associated with higher risk for colorectal adenoma: Multilevel analysis in a prospective cohort","volume":"36","author":"Moon","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.gie.2018.02.040","article-title":"Visceral obesity as a risk factor for colorectal adenoma occurrence in surveillance colonoscopy","volume":"88","author":"Im","year":"2018","journal-title":"Gastrointest. Endosc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ajg.2009.541","article-title":"Visceral obesity and insulin resistance as risk factors for colorectal adenoma: A cross-sectional, case-control study","volume":"105","author":"Kang","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/annonc\/mdu563","article-title":"Visceral adiposity and colorectal adenomas: Dose-response meta-analysis of observational studies","volume":"26","author":"Keum","year":"2015","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1053\/j.gastro.2011.12.050","article-title":"Body mass index increases risk for colorectal adenomas based on meta-analysis","volume":"142","author":"Ben","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1158\/0008-5472.CAN-12-3477","article-title":"Impact of body mass index on the risk of colorectal adenoma in a metabolically healthy population","volume":"73","author":"Yun","year":"2013","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Sinn, D.H., Min, Y.W., Son, H.J., Rhee, P.L., Paik, S.W., Hong, S.N., and Gwak, G.Y. (2017). Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179480"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1053\/j.gastro.2015.06.047","article-title":"Genetics and genetic biomarkers in sporadic colorectal cancer","volume":"149","author":"Carethers","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1055\/s-0043-113445","article-title":"Calculating the adenoma detection rate in screening colonoscopies only: Is it necessary? Can it be gamed?","volume":"49","author":"Rex","year":"2017","journal-title":"Endoscopy"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/annonc\/mdp127","article-title":"Familial colorectal cancer risk: Esmo clinical recommendations","volume":"20","author":"Vasen","year":"2009","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1001\/jama.293.16.2028","article-title":"Progress in genetic testing, classification, and identification of lynch syndrome","volume":"293","author":"Vasen","year":"2005","journal-title":"JAMA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2014.58.9952","article-title":"Obesity, aspirin, and risk of colorectal cancer in carriers of hereditary colorectal cancer: A prospective investigation in the capp2 study","volume":"33","author":"Movahedi","year":"2015","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lazzeroni, M., Bellerba, F., Calvello, M., Macrae, F., Win, A.K., Jenkins, M., Serrano, D., Marabelli, M., Cagnacci, S., and Tolva, G. (2021). A meta-analysis of obesity and risk of colorectal cancer in patients with lynch syndrome: The impact of sex and genetics. Nutrients, 13.","DOI":"10.3390\/nu13051736"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-128-11-199806010-00004","article-title":"Increased risk for cancer in patients with the peutz-jeghers syndrome","volume":"128","author":"Boardman","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Greene, M.W., Abraham, P.T., Kuhlers, P.C., Lipke, E.A., Heslin, M.J., Wijaya, S.T., and Odeniyi, I. (2022). Consensus molecular subtype differences linking colon adenocarcinoma and obesity revealed by a cohort transcriptomic analysis. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0268436"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2024051","DOI":"10.1080\/23723556.2021.2024051","article-title":"Rewired lipid metabolism as an actionable vulnerability of aggressive colorectal carcinoma","volume":"9","author":"Capece","year":"2022","journal-title":"Mol. Cell. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/1878-0261.12772","article-title":"Physical activity, obesity and sedentary behavior in cancer etiology: Epidemiologic evidence and biologic mechanisms","volume":"15","author":"Friedenreich","year":"2021","journal-title":"Mol. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Sanchez, N.F., Stierman, B., Saab, S., Mahajan, D., Yeung, H., and Francois, F. (2012). Physical activity reduces risk for colon polyps in a multiethnic colorectal cancer screening population. BMC Res. Notes, 5.","DOI":"10.1186\/1756-0500-5-312"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s10552-013-0247-4","article-title":"Physical activity and other lifestyle factors in relation to the prevalence of colorectal adenoma: A colonoscopy-based study in asymptomatic Koreans","volume":"24","author":"Song","year":"2013","journal-title":"Cancer Causes Control CCC"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/1940-6207.CAPR-22-0466","article-title":"Associations between physical activity and incidence of cancer among overweight adults in korea: Results from the health examinees-g study","volume":"16","author":"Choi","year":"2023","journal-title":"Cancer Prev. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ijc.34011","article-title":"Interaction of leisure-time physical activity with body mass index on the risk of obesity-related cancers: A pooled study","volume":"151","author":"Sun","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/gut.2005.068189","article-title":"Effect of physical activity and body size on survival after diagnosis with colorectal cancer","volume":"55","author":"Haydon","year":"2006","journal-title":"Gut"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.maturitas.2014.12.017","article-title":"Diet and colorectal cancer","volume":"80","author":"Baena","year":"2015","journal-title":"Maturitas"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"102454","DOI":"10.1016\/j.canep.2023.102454","article-title":"The association of the healthy eating index with risk of colorectal cancers (overall and by subsite) among Canadians","volume":"87","author":"Arthur","year":"2023","journal-title":"Cancer Epidemiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/ijc.33925","article-title":"Composite dietary antioxidant index and the risk of colorectal cancer: Findings from the singapore chinese health study","volume":"150","author":"Yu","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/ijc.30653","article-title":"Abdominal adiposity is not a mediator of the protective effect of mediterranean diet on colorectal cancer","volume":"140","author":"Fasanelli","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10654-013-9795-x","article-title":"Mediterranean diet and colorectal cancer risk: Results from a european cohort","volume":"28","author":"Bamia","year":"2013","journal-title":"Eur. J. Epidemiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e015619","DOI":"10.1136\/bmjopen-2016-015619","article-title":"The association of dietary quality with colorectal cancer among normal weight, overweight and obese men and women: A prospective longitudinal study in the USA","volume":"7","author":"Waring","year":"2017","journal-title":"BMJ Open"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3322\/caac.21601","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00384-020-03585-z","article-title":"Social determinants of colorectal cancer risk, stage, and survival: A systematic review","volume":"35","author":"Coughlin","year":"2020","journal-title":"Int. J. Color. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Adebayo, A.S., Agbaje, K., Adesina, S.K., and Olajubutu, O. (2023). Colorectal cancer: Disease process, current treatment options, and future perspectives. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15112620"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ecco-jcc\/jjac143","article-title":"Perianal crohn\u2019s disease and the development of colorectal and anal cancer: A systematic review and meta-analysis","volume":"17","author":"Johansen","year":"2023","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.21037\/jgo-21-624","article-title":"Correlation of ulcerative colitis and colorectal cancer: A systematic review and meta-analysis","volume":"12","author":"Wang","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10151-019-1926-2","article-title":"Colorectal cancer in inflammatory bowel disease: Review of the evidence","volume":"23","author":"Keller","year":"2019","journal-title":"Tech. Coloproctology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ijc.31100","article-title":"Body fatness at an early age and risk of colorectal cancer","volume":"142","author":"Hidayat","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"812","DOI":"10.14309\/ajg.0000000000001661","article-title":"Link between obesity and early-onset colorectal cancers (eocrc): Importance of accounting for bmi trajectories in early life","volume":"117","author":"Hawwash","year":"2022","journal-title":"Am. J. Gastroenterol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10654-022-00954-6","article-title":"Is the association of overweight and obesity with colorectal cancer underestimated? An umbrella review of systematic reviews and meta-analyses","volume":"38","author":"Mandic","year":"2023","journal-title":"Eur. J. Epidemiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2741\/E596","article-title":"Obesity and colorectal cancer","volume":"5","author":"Aleksandrova","year":"2013","journal-title":"Front. Biosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Chaplin, A., Rodriguez, R.M., Segura-Sampedro, J.J., Ochogavia-Segui, A., Romaguera, D., and Barcelo-Coblijn, G. (2022). Insights behind the relationship between colorectal cancer and obesity: Is visceral adipose tissue the missing link?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113128"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/cvr\/cvx108","article-title":"The role of infiltrating immune cells in dysfunctional adipose tissue","volume":"113","author":"Guzik","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"100939","DOI":"10.1016\/j.neo.2023.100939","article-title":"Targeting il-23 for the interception of obesity-associated colorectal cancer","volume":"45","author":"Madka","year":"2023","journal-title":"Neoplasia"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/cr200084z","article-title":"Free radical lipid peroxidation: Mechanisms and analysis","volume":"111","author":"Yin","year":"2011","journal-title":"Chem. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bbadis.2007.04.009","article-title":"Oxidized phospholipids: From molecular properties to disease","volume":"1772","author":"Fruhwirth","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1021\/tx034248o","article-title":"Induction of apoptosis in colorectal carcinoma cells treated with 4-hydroxy-2-nonenal and structurally related aldehydic products of lipid peroxidation","volume":"17","author":"West","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.redox.2014.12.011","article-title":"Role of lipid peroxidation derived 4-hydroxynonenal (4-hne) in cancer: Focusing on mitochondria","volume":"4","author":"Zhong","year":"2015","journal-title":"Redox Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1073\/pnas.0402794101","article-title":"Trans-4-hydroxy-2-nonenal inhibits nucleotide excision repair in human cells: A possible mechanism for lipid peroxidation-induced carcinogenesis","volume":"101","author":"Feng","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.febslet.2007.04.048","article-title":"The lipid peroxidation end-product 4-hne induces cox-2 expression through p38mapk activation in 3t3-l1 adipose cell","volume":"581","author":"Zarrouki","year":"2007","journal-title":"FEBS Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12967-016-0772-5","article-title":"Obesity and colorectal cancer: Molecular features of adipose tissue","volume":"14","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"31426","DOI":"10.1074\/jbc.M212549200","article-title":"Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells","volume":"278","author":"Niedernhofer","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"44879","DOI":"10.18632\/oncotarget.9821","article-title":"Mitochondrial dysfunction and oxidative stress in aging and cancer","volume":"7","author":"Kudryavtseva","year":"2016","journal-title":"Oncotarget"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Ahechu, P., Zozaya, G., Marti, P., Hernandez-Lizoain, J.L., Baixauli, J., Unamuno, X., Fruhbeck, G., and Catalan, V. (2018). Nlrp3 inflammasome: A possible link between obesity-associated low-grade chronic inflammation and colorectal cancer development. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02918"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13148-018-0493-0","article-title":"Adipose tissue inflammation and vdr expression and methylation in colorectal cancer","volume":"10","author":"Morcillo","year":"2018","journal-title":"Clin. Epigenet."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Park, M.H., and Hong, J.T. (2016). Roles of nf-kappab in cancer and inflammatory diseases and their therapeutic approaches. Cells, 5.","DOI":"10.3390\/cells5020015"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ebiom.2018.02.022","article-title":"Obesity and cancer: Existing and new hypotheses for a causal connection","volume":"30","author":"Stone","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"Stats in cancer inflammation and immunity: A leading role for stat3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2147\/DMSO.S236127","article-title":"The role of jnk signaling pathway in obesity-driven insulin resistance","volume":"13","author":"Feng","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.tem.2021.02.005","article-title":"Old paradoxes and new opportunities for appetite control in obesity","volume":"32","author":"Montegut","year":"2021","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Socol, C.T., Chira, A., Martinez-Sanchez, M.A., Nunez-Sanchez, M.A., Maerescu, C.M., Mierlita, D., Rusu, A.V., Ruiz-Alcaraz, A.J., Trif, M., and Ramos-Molina, B. (2022). Leptin signaling in obesity and colorectal cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094713"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacl.2013.04.001","article-title":"Obesity, adiposity, and dyslipidemia: A consensus statement from the national lipid association","volume":"7","author":"Bays","year":"2013","journal-title":"J. Clin. Lipidol."},{"key":"ref_83","unstructured":"Swarup, S., Ahmed, I., Grigorova, Y., and Zeltser, R. (2024). Metabolic Syndrome. Statpearls, Statpearls."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/oby.23444","article-title":"Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome","volume":"30","author":"Karra","year":"2022","journal-title":"Obesity"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/gutjnl-2020-321661","article-title":"Metabolic syndrome, metabolic comorbid conditions and risk of early-onset colorectal cancer","volume":"70","author":"Chen","year":"2021","journal-title":"Gut"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Crudele, L., De Matteis, C., Novielli, F., Petruzzelli, S., Di Buduo, E., Graziano, G., Cariello, M., Piccinin, E., Gadaleta, R.M., and Moschetta, A. (Intern. Emerg. Med., 2024). Fasting hyperglycaemia and fatty liver drive colorectal cancer: A retrospective analysis in 1145 patients, Intern. Emerg. Med., online ahead of print.","DOI":"10.1007\/s11739-024-03596-6"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.metabol.2015.06.013","article-title":"Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis","volume":"64","author":"Yoon","year":"2015","journal-title":"Metab. Clin. Exp."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41387-024-00283-5","article-title":"Factors associated with body weight gain and insulin-resistance: A longitudinal study","volume":"14","author":"Buscemi","year":"2024","journal-title":"Nutr. Diabetes"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/cncr.26454","article-title":"Insulin resistance, central obesity, and risk of colorectal adenomas","volume":"118","author":"Ortiz","year":"2012","journal-title":"Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.metabol.2018.12.006","article-title":"Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine","volume":"92","author":"Nimptsch","year":"2019","journal-title":"Metab. Clin. Exp."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/ijc.24927","article-title":"Serum levels of igf-i, igfbp-3 and colorectal cancer risk: Results from the epic cohort, plus a meta-analysis of prospective studies","volume":"126","author":"Rinaldi","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1200\/JCO.2008.17.9945","article-title":"Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer","volume":"27","author":"Wolpin","year":"2009","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/curroncol31020075","article-title":"Insulin resistance: The increased risk of cancers","volume":"31","author":"Szablewski","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1078-0432.CCR-23-3964","article-title":"Clinical challenges of consensus molecular subtype cms4 colon cancer in the era of precision medicine","volume":"30","author":"Cazelles","year":"2024","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s10654-021-00741-9","article-title":"Consumption of red meat and processed meat and cancer incidence: A systematic review and meta-analysis of prospective studies","volume":"36","author":"Farvid","year":"2021","journal-title":"Eur. J. Epidemiol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Vernia, F., Longo, S., Stefanelli, G., Viscido, A., and Latella, G. (2021). Dietary factors modulating colorectal carcinogenesis. Nutrients, 13.","DOI":"10.3390\/nu13010143"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/nutrit\/nuac065","article-title":"An overview of vitamins as epidrugs for colorectal cancer prevention","volume":"81","author":"Boughanem","year":"2023","journal-title":"Nutr. Rev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1080\/10408398.2013.873886","article-title":"Mechanisms linking colorectal cancer to the consumption of (processed) red meat: A review","volume":"56","author":"Demeyer","year":"2016","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.scitotenv.2013.11.127","article-title":"Assessment of current dietary intake of organochlorine contaminants and polycyclic aromatic hydrocarbons in killer whales (orcinus orca) through direct determination in a group of whales in captivity","volume":"472","author":"Formigaro","year":"2014","journal-title":"Sci. Total Environ."},{"key":"ref_101","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2018). Red meat and processed meat. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1093\/nar\/gkq1349","article-title":"Translational recoding as a feedback controller: Systems approaches reveal polyamine-specific effects on the antizyme ribosomal frameshift","volume":"39","author":"Rato","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Gutierrez, L.G., Hernandez-Morales, M., Nunez, L., and Villalobos, C. (2019). Inhibition of polyamine biosynthesis reverses ca(2+) channel remodeling in colon cancer cells. Cancers, 11.","DOI":"10.3390\/cancers11010083"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1073\/pnas.90.16.7804","article-title":"The ornithine decarboxylase gene is a transcriptional target of c-myc","volume":"90","author":"Packham","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.4161\/cbt.5.12.3376","article-title":"Role of c-myc in intestinal tumorigenesis of the apcmin\/+ mouse","volume":"5","author":"Ignatenko","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1053\/j.gastro.2021.11.005","article-title":"Protective role of spermidine in colitis and colon carcinogenesis","volume":"162","author":"Gobert","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s43587-022-00322-9","article-title":"Mechanisms of spermidine-induced autophagy and geroprotection","volume":"2","author":"Hofer","year":"2022","journal-title":"Nat. Aging"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Del Corno, M., Vari, R., Scazzocchio, B., Varano, B., Masella, R., and Conti, L. (2021). Dietary fatty acids at the crossroad between obesity and colorectal cancer: Fine regulators of adipose tissue homeostasis and immune response. Cells, 10.","DOI":"10.3390\/cells10071738"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.08.056","article-title":"Roles for interleukin 17 and adaptive immunity in pathogenesis of colorectal cancer","volume":"155","author":"Hurtado","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"120","DOI":"10.20892\/j.issn.2095-3941.2015.0103","article-title":"Colorectal cancer carcinogenesis: A review of mechanisms","volume":"13","author":"Tariq","year":"2016","journal-title":"Cancer Biol. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.gastro.2019.08.059","article-title":"Pathways of colorectal carcinogenesis","volume":"158","author":"Nguyen","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1158\/2159-8290.CD-17-0909","article-title":"Macrod2 haploinsufficiency impairs catalytic activity of parp1 and promotes chromosome instability and growth of intestinal tumors","volume":"8","author":"Sakthianandeswaren","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Malki, A., ElRuz, R.A., Gupta, I., Allouch, A., Vranic, S., and Al Moustafa, A.E. (2020). Molecular mechanisms of colon cancer progression and metastasis: Recent insights and advancements. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010130"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejca.2022.07.020","article-title":"Deficient mismatch repair\/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment","volume":"175","author":"Taieb","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_116","first-page":"3455","article-title":"Hypermethylation of the hmlh1 promoter in colon cancer with microsatellite instability","volume":"58","author":"Cunningham","year":"1998","journal-title":"Cancer Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1158\/0008-5472.CAN-2401-2","article-title":"Frequent inactivation of pten by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers","volume":"64","author":"Goel","year":"2004","journal-title":"Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.onc.1207059","article-title":"Pten mutations are common in sporadic microsatellite stable colorectal cancer","volume":"23","author":"Nassif","year":"2004","journal-title":"Oncogene"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41525-023-00384-7","article-title":"Source, co-occurrence, and prognostic value of pten mutations or loss in colorectal cancer","volume":"8","author":"Serebriiskii","year":"2023","journal-title":"NPJ Genom. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/j.gastro.2006.09.018","article-title":"The cpg island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer","volume":"132","author":"Goel","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Dong, L., Ma, L., Ma, G.H., and Ren, H. (2019). Genome-wide analysis reveals DNA methylation alterations in obesity associated with high risk of colorectal cancer. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-41616-0"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41366-018-0065-6","article-title":"Identification of an episignature of human colorectal cancer associated with obesity by genome-wide DNA methylation analysis","volume":"43","author":"Crujeiras","year":"2019","journal-title":"Int. J. Obes."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/88871","article-title":"Telomere dysfunction and evolution of intestinal carcinoma in mice and humans","volume":"28","author":"Rudolph","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1158\/1078-0432.CCR-0984-03","article-title":"Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis","volume":"10","author":"Meeker","year":"2004","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/jnci\/djt191","article-title":"Extensive telomere erosion in the initiation of colorectal adenomas and its association with chromosomal instability","volume":"105","author":"Roger","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/ijc.30288","article-title":"Telomere structure and maintenance gene variants and risk of five cancer types","volume":"139","author":"Karami","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.devcel.2024.03.020","article-title":"Telomere dysfunction alters intestinal stem cell dynamics to promote cancer","volume":"59","author":"LaBella","year":"2024","journal-title":"Dev. Cell"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3892\/mco.2021.2346","article-title":"Obesity and telomere status in the prognosis of patients with colorectal cancer submitted to curative intention surgical treatment","volume":"15","author":"Tesolato","year":"2021","journal-title":"Mol. Clin. Oncol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clnu.2011.09.003","article-title":"Colonocyte telomere shortening is greater with dietary red meat than white meat and is attenuated by resistant starch","volume":"31","author":"Toden","year":"2012","journal-title":"Clin. Nutr."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Garcia-Martinez, S., Gonzalez-Gamo, D., Tesolato, S.E., Barabash, A., de la Serna, S.C., Dominguez-Serrano, I., Dziakova, J., Rivera, D., Torres, A.J., and Iniesta, P. (2022). Telomere length and telomerase activity in subcutaneous and visceral adipose tissues from obese and non-obese patients with and without colorectal cancer. Cancers, 15.","DOI":"10.3390\/cancers15010273"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1387\/ijdb.041815jb","article-title":"The wnt connection to tumorigenesis","volume":"48","author":"Behrens","year":"2004","journal-title":"Int. J. Dev. Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","article-title":"Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target","volume":"21","author":"Zhao","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Stefani, C., Miricescu, D., Stanescu, S., Nica, R.I., Greabu, M., Totan, A.R., and Jinga, M. (2021). Growth factors, pi3k\/akt\/mtor and mapk signaling pathways in colorectal cancer pathogenesis: Where are we now?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910260"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1467-789X.2009.00607.x","article-title":"Obesity, the pi3k\/akt signal pathway and colon cancer","volume":"10","author":"Huang","year":"2009","journal-title":"Obes. Rev. Off. J. Int. Assoc. Study Obes."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1467-789X.2011.00917.x","article-title":"Multiple signal pathways in obesity-associated cancer","volume":"12","author":"Chen","year":"2011","journal-title":"Obes. Rev. Off. J. Int. Assoc. Study Obes."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1101\/gad.348226.120","article-title":"Genetic and biological hallmarks of colorectal cancer","volume":"35","author":"Li","year":"2021","journal-title":"Genes Dev."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.semcdb.2019.05.018","article-title":"Metabolic pathways regulating colorectal cancer initiation and progression","volume":"98","author":"Sebastian","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5306\/wjco.v11.i10.761","article-title":"Colorectal liver metastases: Current management and future perspectives","volume":"11","author":"Martin","year":"2020","journal-title":"World J. Clin. Oncol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.cmet.2018.04.003","article-title":"Aldolase b-mediated fructose metabolism drives metabolic reprogramming of colon cancer liver metastasis","volume":"27","author":"Bu","year":"2018","journal-title":"Cell Metab."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12944-024-02024-0","article-title":"Reprogramming of lipid metabolism in the tumor microenvironment: A strategy for tumor immunotherapy","volume":"23","author":"Wu","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Yang, M., Zhu, C., Du, L., Huang, J., Lu, J., Yang, J., Tong, Y., Zhu, M., Song, C., and Shen, C. (2023). A metabolomic signature of obesity and risk of colorectal cancer: Two nested case-control studies. Metabolites, 13.","DOI":"10.3390\/metabo13020234"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"577","DOI":"10.12998\/wjcc.v6.i13.577","article-title":"Role of bile acids in colon carcinogenesis","volume":"6","author":"Nguyen","year":"2018","journal-title":"World J. Clin. Cases"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.3748\/wjg.v25.i31.4383","article-title":"Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance","volume":"25","author":"Tuomisto","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.07.013","article-title":"Ikkbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer","volume":"118","author":"Greten","year":"2004","journal-title":"Cell"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2012.12.012","article-title":"Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties","volume":"152","author":"Schwitalla","year":"2013","journal-title":"Cell"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1610502","DOI":"10.3389\/pore.2022.1610502","article-title":"The role of tumor microenvironment and immune response in colorectal cancer development and prognosis","volume":"28","author":"Wozniakova","year":"2022","journal-title":"Pathol. Oncol. Res. POR"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Saman, H., Raza, S.S., Uddin, S., and Rasul, K. (2020). Inducing angiogenesis, a key step in cancer vascularization, and treatment approaches. Cancers, 12.","DOI":"10.20944\/preprints202004.0400.v1"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/0008-5472.CAN-13-1641","article-title":"Vegf-mediated angiogenesis links emt-induced cancer stemness to tumor initiation","volume":"74","author":"Fantozzi","year":"2014","journal-title":"Cancer Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Lu, J., Kornmann, M., and Traub, B. (2023). Role of epithelial to mesenchymal transition in colorectal cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914815"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.canlet.2014.08.012","article-title":"Sdf-1\/cxcr4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the wnt\/beta-catenin signaling pathway","volume":"354","author":"Hu","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Zhang, X.L., Zhang, X.F., Fang, Y., Li, M.L., Shu, R., Gong, Y., Luo, H.Y., and Tian, Y. (2023). A possible genetic association between obesity and colon cancer in females. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1189570"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12967-024-04921-5","article-title":"Single-cell transcriptome analysis reveals immunosuppressive landscape in overweight and obese colorectal cancer","volume":"22","author":"Xiao","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ccr.2012.11.014","article-title":"Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors","volume":"23","author":"Schwitalla","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Xu, P., Tao, Z., Yang, H., and Zhang, C. (2024). Obesity and early-onset colorectal cancer risk: Emerging clinical evidence and biological mechanisms. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1366544"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: A meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Heo, G., Lee, Y., and Im, E. (2021). Interplay between the gut microbiota and inflammatory mediators in the development of colorectal cancer. Cancers, 13.","DOI":"10.3390\/cancers13040734"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1373\/clinchem.2016.267666","article-title":"Oncometabolites: A new paradigm for oncology, metabolism, and the clinical laboratory","volume":"63","author":"Collins","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","article-title":"Mutational signature in colorectal cancer caused by genotoxic pks(+) e. Coli","volume":"580","author":"Puschhof","year":"2020","journal-title":"Nature"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/jnci\/djt300","article-title":"Human gut microbiome and risk for colorectal cancer","volume":"105","author":"Ahn","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Messaritakis, I., Koulouris, A., Boukla, E., Vogiatzoglou, K., Lagkouvardos, I., Intze, E., Sfakianaki, M., Chondrozoumaki, M., Karagianni, M., and Athanasakis, E. (2024). Exploring gut microbiome composition and circulating microbial DNA fragments in patients with stage ii\/iii colorectal cancer: A comprehensive analysis. Cancers, 16.","DOI":"10.3390\/cancers16101923"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","article-title":"Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer","volume":"25","author":"Wirbel","year":"2019","journal-title":"Nat. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jare.2022.12.015","article-title":"Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer","volume":"52","author":"Tsai","year":"2023","journal-title":"J. Adv. Res."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Cheng, Y., Ling, Z., and Li, L. (2020). The intestinal microbiota and colorectal cancer. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.615056"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrmicro2819","article-title":"A bacterial driver-passenger model for colorectal cancer: Beyond the usual suspects","volume":"10","author":"Tjalsma","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Duan, M., Wang, Y., Zhang, Q., Zou, R., Guo, M., and Zheng, H. (2021). Characteristics of gut microbiota in people with obesity. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0255446"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","article-title":"Short-chain fatty acids in diseases","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun. Signal. CCS"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1753-4887.2009.00224.x","article-title":"Diet, fecal water, and colon cancer-development of a biomarker","volume":"67","author":"Pearson","year":"2009","journal-title":"Nutr. Rev."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4161\/gmic.21216","article-title":"Is bile acid a determinant of the gut microbiota on a high-fat diet?","volume":"3","author":"Yokota","year":"2012","journal-title":"Gut Microbes"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbalip.2016.04.006","article-title":"Deoxycholic acid mediates non-canonical egfr-mapk activation through the induction of calcium signaling in colon cancer cells","volume":"1861","author":"Centuori","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_172","first-page":"581","article-title":"Delphi initiative for early-onset colorectal cancer (direct) international management guidelines","volume":"21","author":"Cavestro","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jval.2019.07.004","article-title":"Excess costs and economic burden of obesity-related cancers in the united states","volume":"22","author":"Hong","year":"2019","journal-title":"Value Health J. Int. Soc. Pharmacoecon. Outcomes Res."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/archsurg.2011.117","article-title":"Surgical site infections and cost in obese patients undergoing colorectal surgery","volume":"146","author":"Wick","year":"2011","journal-title":"Arch. Surg."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"e217501","DOI":"10.1001\/jamanetworkopen.2021.7501","article-title":"Cost-effectiveness analysis of nutrition facts added-sugar labeling and obesity-associated cancer rates in the us","volume":"4","author":"Du","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_176","first-page":"507","article-title":"Cost-effectiveness of earlier or more intensive colorectal cancer screening in overweight and obese patients","volume":"21","author":"Yeoh","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1016\/j.ejca.2013.04.032","article-title":"Eurecca colorectal: Multidisciplinary mission statement on better care for patients with colon and rectal cancer in europe","volume":"49","author":"Aristei","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Ahuja, V. (2011). 14\u2014Open surgical techniques in colorectal cancer. Early Diagnosis and Treatment of Cancer Series: Colorectal Cancer, Elsevier.","DOI":"10.1016\/B978-1-4160-4686-8.50019-1"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Petrou, N.A., Rafique, H., Rasheed, S., Tekkis, P., and Kontovounisios, C. (2022). Colorectal cancer and the obese patient: A call for guidelines. Cancers, 14.","DOI":"10.3390\/cancers14215255"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.amjsurg.2013.05.016","article-title":"Obesity, outcomes and quality of care: Body mass index increases the risk of wound-related complications in colon cancer surgery","volume":"207","author":"Amri","year":"2014","journal-title":"Am. J. Surg."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S1470-2045(14)70486-3","article-title":"Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage iii colon cancer and the effect of oxaliplatin on post-relapse survival: A pooled analysis of individual patient data from four randomised controlled trials","volume":"15","author":"Schmoll","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_182","first-page":"1","article-title":"Treatment of patients with early-stage colorectal cancer: Asco resource-stratified guideline","volume":"5","author":"Nandakumar","year":"2019","journal-title":"J. Glob. Oncol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/cncr.31976","article-title":"Obesity and cancer treatment efficacy: Existing challenges and opportunities","volume":"125","author":"Ross","year":"2019","journal-title":"Cancer"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.2217\/fon-2020-1238","article-title":"Trifluridine\/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: Sunlight study design","volume":"17","author":"Tabernero","year":"2021","journal-title":"Future Oncol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"E708","DOI":"10.1055\/a-0808-3680","article-title":"Hot snare vs. Cold snare polypectomy for endoscopic removal of 4\u201310 mm colorectal polyps during colonoscopy: A systematic review and meta-analysis of randomized controlled studies","volume":"7","author":"Jegadeesan","year":"2019","journal-title":"Endosc. Int. Open"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1007\/s10620-016-4314-z","article-title":"Endoscopic management of large (>\/=2 cm) non-pedunculated colorectal polyps: Impact of polyp morphology on outcomes","volume":"61","author":"Lim","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Dekkers, N., Dang, H., Vork, K., Langers, A.M.J., van der Kraan, J., Westerterp, M., Peeters, K., Holman, F.A., Koch, A.D., and de Graaf, W. (2023). Outcome of completion surgery after endoscopic submucosal dissection in early-stage colorectal cancer patients. Cancers, 15.","DOI":"10.3390\/cancers15184490"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.gie.2023.02.027","article-title":"Long-term outcomes of local resection versus surgical resection for high-risk t1 colorectal cancer: A systematic review and meta-analysis","volume":"97","author":"Chen","year":"2023","journal-title":"Gastrointest. Endosc."},{"key":"ref_189","first-page":"66","article-title":"Transanal total mesorectal excision for patients with rectal cancer: A systematic review and meta-analysis","volume":"1","author":"Ziati","year":"2021","journal-title":"Gulf J. Oncol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.suronc.2004.08.002","article-title":"Colorectal cancer presenting as surgical emergencies","volume":"13","author":"Cuffy","year":"2004","journal-title":"Surg. Oncol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1245\/s10434-022-12848-8","article-title":"The extraperitoneal approach to left-sided colorectal rectal resections: Experts procedure","volume":"30","author":"Hany","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jama.2017.7219","article-title":"Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: The rolarr randomized clinical trial","volume":"318","author":"Jayne","year":"2017","journal-title":"JAMA"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/DCR.0000000000001490","article-title":"Factors predicting operative difficulty of laparoscopic total mesorectal excision","volume":"62","author":"Curtis","year":"2019","journal-title":"Dis. Colon Rectum"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1007\/s00464-019-07000-9","article-title":"The impact of robotic colorectal surgery in obese patients: A systematic review, meta-analysis, and meta-regression","volume":"33","author":"Wee","year":"2019","journal-title":"Surg. Endosc."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Tam, S.Y., and Wu, V.W.C. (2019). A review on the special radiotherapy techniques of colorectal cancer. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00208"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13014-016-0752-1","article-title":"Intraoperative radiation therapy for colon and rectal cancers: A clinical review","volume":"12","author":"Haddock","year":"2017","journal-title":"Radiat. Oncol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2468-1253(19)30329-2","article-title":"The global challenge of colorectal cancer","volume":"4","author":"Guren","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12032-022-01864-z","article-title":"Regulation of thymidylate synthase: An approach to overcome 5-fu resistance in colorectal cancer","volume":"40","author":"Kumar","year":"2022","journal-title":"Med. Oncol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clinthera.2005.01.005","article-title":"Capecitabine: A review","volume":"27","author":"Walko","year":"2005","journal-title":"Clin. Ther."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Krauss, J., and Bracher, F. (2018). Pharmacokinetic enhancers (boosters)-escort for drugs against degrading enzymes and beyond. Sci. Pharm., 86.","DOI":"10.3390\/scipharm86040043"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10147-014-0675-5","article-title":"Phase ii study of first-line chemotherapy with uracil-tegafur plus oral leucovorin in elderly (>\/=75 years) Japanese patients with metastatic colorectal cancer: Sgosg-cr0501 study","volume":"20","author":"Matsumoto","year":"2015","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s40265-019-01195-w","article-title":"Trifluridine\/tipiracil: A review in metastatic gastric cancer","volume":"79","author":"Kang","year":"2019","journal-title":"Drugs"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00280-015-2850-4","article-title":"Phase 1 study of oral tas-102 in patients with refractory metastatic colorectal cancer","volume":"76","author":"Bendell","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Kciuk, M., Marciniak, B., and Kontek, R. (2020). Irinotecan-still an important player in cancer chemotherapy: A comprehensive overview. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21144919"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1038\/s41467-023-38032-4","article-title":"Final results of destiny-crc01 investigating trastuzumab deruxtecan in patients with her2-expressing metastatic colorectal cancer","volume":"14","author":"Yoshino","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrd1287","article-title":"Oxaliplatin","volume":"3","author":"Graham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: A review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/bjc.2017.238","article-title":"Intracrine vegf signalling mediates colorectal cancer cell migration and invasion","volume":"117","author":"Bhattacharya","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11523-017-0518-1","article-title":"Bevacizumab in colorectal cancer: Current role in treatment and the potential of biosimilars","volume":"12","author":"Rosen","year":"2017","journal-title":"Target. Oncol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1097\/MS9.0000000000000981","article-title":"Bevacizumab side effects and adverse clinical complications in colorectal cancer patients: Review article","volume":"85","author":"Minhajat","year":"2023","journal-title":"Ann. Med. Surg."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.xkme.2020.11.011","article-title":"Lupus-like glomerulonephritis associated with regorafenib, a multikinase inhibitor","volume":"3","author":"Strasma","year":"2021","journal-title":"Kidney Med."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejca.2022.03.026","article-title":"A phase i\/ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer","volume":"169","author":"Kim","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Guerrero, P., Albarran, V., San Roman, M., Gonzalez-Merino, C., Garcia de Quevedo, C., Moreno, J., Calvo, J.C., Gonzalez, G., Orejana, I., and Chamorro, J. (2023). Braf inhibitors in metastatic colorectal cancer and mechanisms of resistance: A review of the literature. Cancers, 15.","DOI":"10.3390\/cancers15215243"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","article-title":"Encorafenib, binimetinib, and cetuximab in braf v600e-mutated colorectal cancer","volume":"381","author":"Kopetz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_217","first-page":"95","article-title":"The role of the epidermal growth factor receptor in the mechanism and treatment of colorectal cancer","volume":"11","author":"Yarom","year":"2011","journal-title":"Discov. Med."},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Garcia-Foncillas, J., Sunakawa, Y., Aderka, D., Wainberg, Z., Ronga, P., Witzler, P., and Stintzing, S. (2019). Distinguishing features of cetuximab and panitumumab in colorectal cancer and other solid tumors. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00849"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/djz093","article-title":"Immunotherapy for colorectal cancer: A review of current and novel therapeutic approaches","volume":"111","author":"Franke","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Makaremi, S., Asadzadeh, Z., Hemmat, N., Baghbanzadeh, A., Sgambato, A., Ghorbaninezhad, F., Safarpour, H., Argentiero, A., Brunetti, O., and Bernardini, R. (2021). Immune checkpoint inhibitors in colorectal cancer: Challenges and future prospects. Biomedicines, 9.","DOI":"10.3390\/biomedicines9091075"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1470-2045(20)30087-5","article-title":"Folfoxiri reintroduction in metastatic colorectal cancer","volume":"21","author":"Harrison","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S1470-2045(14)70330-4","article-title":"Folfiri plus cetuximab versus folfiri plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (fire-3): A randomised, open-label, phase 3 trial","volume":"15","author":"Heinemann","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1470-2045(19)30862-9","article-title":"Upfront folfoxiri plus bevacizumab and reintroduction after progression versus mfolfox6 plus bevacizumab followed by folfiri plus bevacizumab in the treatment of patients with metastatic colorectal cancer (tribe2): A multicentre, open-label, phase 3, randomised, controlled trial","volume":"21","author":"Cremolini","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1200\/JCO.2018.78.3183","article-title":"Efficacy and tolerability of first-line cetuximab plus leucovorin, fluorouracil, and oxaliplatin (folfox-4) versus folfox-4 in patients with ras wild-type metastatic colorectal cancer: The open-label, randomized, phase iii tailor trial","volume":"36","author":"Qin","year":"2018","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1470-2045(14)70028-2","article-title":"Definitive chemoradiotherapy with folfox versus fluorouracil and cisplatin in patients with oesophageal cancer (prodige5\/accord17): Final results of a randomised, phase 2\/3 trial","volume":"15","author":"Conroy","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","article-title":"Neoadjuvant immunotherapy leads to pathological responses in mmr-proficient and mmr-deficient early-stage colon cancers","volume":"26","author":"Chalabi","year":"2020","journal-title":"Nat. Med."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/s41591-022-01930-z","article-title":"Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer","volume":"28","author":"Chatila","year":"2022","journal-title":"Nat. Med."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3322\/caac.21818","article-title":"Immunosurveillance in clinical cancer management","volume":"74","author":"Kroemer","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Xia, F., Wang, Y., Wang, H., Shen, L., Xiang, Z., Zhao, Y., Zhang, H., Wan, J., Zhang, H., and Wang, Y. (2024). Randomized phase ii trial of immunotherapy-based total neoadjuvant therapy for proficient mismatch repair or microsatellite stable locally advanced rectal cancer (torch). J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol., JCO2302261.","DOI":"10.1200\/JCO.23.02261"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.semcancer.2023.02.008","article-title":"The role of exercise in obesity-related cancers: Current evidence and biological mechanisms","volume":"91","author":"Larson","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000442721","article-title":"European guidelines for obesity management in adults","volume":"8","author":"Yumuk","year":"2015","journal-title":"Obes. Facts"},{"key":"ref_233","first-page":"1","article-title":"American association of clinical endocrinologists and american college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr. Pract. Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: A clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ Can. Med. Assoc. J. = J. L\u2019association Medicale Can."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Busetto, L., Dicker, D., Fruhbeck, G., Halford, J.C.G., Sbraccia, P., Yumuk, V., and Goossens, G.H. (Nat. Med., 2024). A new framework for the diagnosis, staging and management of obesity in adults, Nat. Med., online ahead of print.","DOI":"10.1038\/s41591-024-03095-3"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/bjs.11494","article-title":"Role of bariatric surgery in reducing the risk of colorectal cancer: A meta-analysis","volume":"107","author":"Almazeedi","year":"2020","journal-title":"Br. J. Surg."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/jnci\/dji375","article-title":"Diabetes mellitus and risk of colorectal cancer: A meta-analysis","volume":"97","author":"Larsson","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/clinem\/dgad450","article-title":"New horizons: Epidemiology of obesity, diabetes mellitus, and cancer prognosis","volume":"109","author":"Harborg","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1053\/j.gastro.2007.03.050","article-title":"The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas","volume":"132","author":"Giovannucci","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_240","first-page":"697521","article-title":"The role of chronic inflammation in obesity-associated cancers","volume":"2013","year":"2013","journal-title":"ISRN Oncol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.62347\/NYHH3132","article-title":"Effect of hyperglycemia on the occurrence and prognosis of colorectal cancer","volume":"16","author":"Zhao","year":"2024","journal-title":"Am. J. Transl. Res."},{"key":"ref_242","first-page":"e930921","article-title":"Hyperglycemia promotes liver metastasis of colorectal cancer via upregulation of integrin alphavbeta6","volume":"27","author":"Wang","year":"2021","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41420-023-01770-x","article-title":"Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent egfr palmitoylation","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Semmler, G., Balcar, L., Wernly, S., Volkerer, A., Semmler, L., Hauptmann, L., Wernly, B., Aigner, E., Niederseer, D., and Datz, C. (2023). Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1244405"},{"key":"ref_245","first-page":"378","article-title":"Drug-induced liver injury caused by capecitabine: A case report and a literature review","volume":"16","author":"Hussein","year":"2023","journal-title":"Case Rep. Oncol."},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Hsu, S.H., Syu, D.K., Chen, Y.C., Liu, C.K., Sun, C.A., and Chen, M. (2022). The association between hypertriglyceridemia and colorectal cancer: A long-term community cohort study in taiwan. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19137804"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4143\/crt.2023.753","article-title":"The persistence of hypertriglyceridemia and the risk of early onset colorectal cancer according to tumor subsites: A nationwide population-based study","volume":"56","author":"Chang","year":"2024","journal-title":"Cancer Res. Treat."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/jnci\/djac011","article-title":"Associations between glycemic traits and colorectal cancer: A mendelian randomization analysis","volume":"114","author":"Murphy","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/sjg.SJG_295_17","article-title":"Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis","volume":"24","author":"Liu","year":"2018","journal-title":"Saudi J. Gastroenterol. Off. J. Saudi Gastroenterol. Assoc."},{"key":"ref_250","doi-asserted-by":"crossref","unstructured":"Palacios-Ramirez, R., Hernanz, R., Martin, A., Perez-Giron, J.V., Barrus, M.T., Gonzalez-Carnicero, Z., Aguado, A., Jaisser, F., Briones, A.M., and Salaices, M. (2019). Pioglitazone modulates the vascular contractility in hypertension by interference with et-1 pathway. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-52839-6"},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Schockel, L., Woischke, C., Surendran, S.A., Michl, M., Schiergens, T., Holscher, A., Glass, F., Kreissl, P., Klauschen, F., and Gunther, M. (2024). Pparg activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil. BMC Cancer, 24.","DOI":"10.1186\/s12885-024-11985-5"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"122083","DOI":"10.1016\/j.lfs.2023.122083","article-title":"Combination chemotherapy against colorectal cancer cells: Co-delivery of capecitabine and pioglitazone hydrochloride by polycaprolactone-polyethylene glycol carriers","volume":"332","author":"Pouya","year":"2023","journal-title":"Life Sci."},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Tikoo, K., Kumar, P., and Gupta, J. (2009). Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benzaanthracene (dmba) induced breast cancer rats. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-107"},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Zanardelli, M., Micheli, L., Cinci, L., Failli, P., Ghelardini, C., and Di Cesare Mannelli, L. (2014). Oxaliplatin neurotoxicity involves peroxisome alterations. Ppargamma agonism as preventive pharmacological approach. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102758"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"102566","DOI":"10.1016\/j.canep.2024.102566","article-title":"Metformin\u2019s role in lowering colorectal cancer risk among individuals with diabetes from the southern community cohort study","volume":"90","author":"Lawler","year":"2024","journal-title":"Cancer Epidemiol."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/CEJ.0000000000000872","article-title":"Association of metformin and statin uses with the prognosis of colon cancer: A meta-analysis","volume":"33","author":"Xu","year":"2024","journal-title":"Eur. J. Cancer Prev. Off. J. Eur. Cancer Prev. Organ."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"13012","DOI":"10.1073\/pnas.1918845117","article-title":"Metformin selectively inhibits metastatic colorectal cancer with the kras mutation by intracellular accumulation through silencing mate1","volume":"117","author":"Xie","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Coronel-Hernandez, J., Salgado-Garcia, R., Cantu-De Leon, D., Jacobo-Herrera, N., Millan-Catalan, O., Delgado-Waldo, I., Campos-Parra, A.D., Rodriguez-Morales, M., Delgado-Buenrostro, N.L., and Perez-Plasencia, C. (2021). Combination of metformin, sodium oxamate and doxorubicin induces apoptosis and autophagy in colorectal cancer cells via downregulation hif-1alpha. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.594200"},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Zhang, X., Cao, L., Xu, G., He, H., Zhao, H., and Liu, T. (2022). Co-delivery of sorafenib and metformin from amphiphilic polypeptide-based micelles for colon cancer treatment. Front. Med., 9.","DOI":"10.3389\/fmed.2022.1009496"},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Yip, K.L., Tsai, T.N., Yang, I.P., Miao, Z.F., Chen, Y.C., Li, C.C., Su, W.C., Chang, T.K., Huang, C.W., and Tsai, H.L. (2022). Metformin enhancement of therapeutic effects of 5-fluorouracil and oxaliplatin in colon cancer cells and nude mice. Biomedicines, 10.","DOI":"10.3390\/biomedicines10050955"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1758835919866964","DOI":"10.1177\/1758835919866964","article-title":"High blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage iii colorectal cancer receiving adjuvant folfox6 chemotherapy","volume":"11","author":"Yang","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1002\/jcb.26898","article-title":"Metformin increases the cytotoxicity of oxaliplatin in human dld-1 colorectal cancer cells through down-regulating hmgb1 expression","volume":"119","author":"Huang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jconrel.2022.09.013","article-title":"Liposomal oxaliplatin prodrugs loaded with metformin potentiate immunotherapy for colorectal cancer","volume":"350","author":"Song","year":"2022","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/2326-6066.CIR-16-0103","article-title":"Efficacy of pd-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia","volume":"5","author":"Scharping","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"e007235","DOI":"10.1136\/jitc-2023-007235","article-title":"Phase ii trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer","volume":"11","author":"Akce","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1940-6207.CAPR-20-0580","article-title":"The effect of metformin in treatment of adenomas in patients with familial adenomatous polyposis","volume":"14","author":"Park","year":"2021","journal-title":"Cancer Prev. Res."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"101658","DOI":"10.1016\/j.canep.2019.101658","article-title":"Anti-diabetic medications and the risk for colorectal cancer: A population-based nested case-control study","volume":"64","author":"Shin","year":"2020","journal-title":"Cancer Epidemiol."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/2042098614523031","article-title":"Safety of dipeptidyl peptidase 4 inhibitors: A perspective review","volume":"5","author":"Karagiannis","year":"2014","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00592-020-01479-8","article-title":"Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: An extensive meta-analysis of randomized controlled trials","volume":"57","author":"Dicembrini","year":"2020","journal-title":"Acta Diabetol."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/s41591-024-02996-7","article-title":"Long-term weight loss effects of semaglutide in obesity without diabetes in the select trial","volume":"30","author":"Ryan","year":"2024","journal-title":"Nat. Med."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/cas.14824","article-title":"Body mass index and colorectal cancer risk: A mendelian randomization study","volume":"112","author":"Suzuki","year":"2021","journal-title":"Cancer Sci."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"e2421305","DOI":"10.1001\/jamanetworkopen.2024.21305","article-title":"Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_273","doi-asserted-by":"crossref","unstructured":"Sun, Y., Liu, Y., Dian, Y., Zeng, F., Deng, G., and Lei, S. (Int. J. Surg., 2024). Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target mendelian randomization and clinical trials, Int. J. Surg., online ahead of print.","DOI":"10.1097\/JS9.0000000000001514"},{"key":"ref_274","doi-asserted-by":"crossref","unstructured":"Shah, C., Hong, Y.R., Bishnoi, R., Ali, A., Skelton, W.P.t., Dang, L.H., Huo, J., and Dang, N.H. (2020). Impact of dpp4 inhibitors in survival of patients with prostate, pancreas, and breast cancer. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00405"},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Kosowska, A., Garczorz, W., Klych-Ratuszny, A., Aghdam, M.R.F., Kimsa-Furdzik, M., Simka-Lampa, K., and Francuz, T. (2020). Sitagliptin modulates the response of ovarian cancer cells to chemotherapeutic agents. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21238976"},{"key":"ref_276","doi-asserted-by":"crossref","unstructured":"Wilson, A.L., Moffitt, L.R., Wilson, K.L., Bilandzic, M., Wright, M.D., Gorrell, M.D., Oehler, M.K., Plebanski, M., and Stephens, A.N. (2021). Dpp4 inhibitor sitagliptin enhances lymphocyte recruitment and prolongs survival in a syngeneic ovarian cancer mouse model. Cancers, 13.","DOI":"10.3390\/cancers13030487"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2337\/dc15-0563","article-title":"Use of an alpha-glucosidase inhibitor and the risk of colorectal cancer in patients with diabetes: A nationwide, population-based cohort study","volume":"38","author":"Tseng","year":"2015","journal-title":"Diabetes Care"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"97862","DOI":"10.18632\/oncotarget.18416","article-title":"Alpha-glucosidase inhibitor use is associated with decreased colorectal neoplasia risk in patients with type 2 diabetes mellitus receiving colonoscopy: A retrospective study","volume":"8","author":"Horibe","year":"2017","journal-title":"Oncotarget"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40265-014-0337-y","article-title":"Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (sglt2) inhibitors for the treatment of type 2 diabetes mellitus","volume":"75","author":"Scheen","year":"2015","journal-title":"Drugs"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1007\/s00125-017-4370-8","article-title":"Sglt2 inhibitors and risk of cancer in type 2 diabetes: A systematic review and meta-analysis of randomised controlled trials","volume":"60","author":"Tang","year":"2017","journal-title":"Diabetologia"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejim.2023.01.021","article-title":"Lower risks of incident colorectal cancer in sglt2i users compared to dpp4i users: A propensity score-matched study with competing risk analysis","volume":"110","author":"Chan","year":"2023","journal-title":"Eur. J. Intern. Med."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.clcc.2017.09.005","article-title":"Sodium glucose cotransporter 2 inhibition combined with cetuximab significantly reduced tumor size and carcinoembryonic antigen level in colon cancer metastatic to liver","volume":"17","author":"Okada","year":"2018","journal-title":"Clin. Color. Cancer"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s11154-021-09675-9","article-title":"Repurposing sodium-glucose co-transporter 2 inhibitors (sglt2i) for cancer treatment\u2014A review","volume":"22","author":"Lau","year":"2021","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_284","doi-asserted-by":"crossref","unstructured":"Anastasio, C., Donisi, I., Del Vecchio, V., Colloca, A., Mele, L., Sardu, C., Marfella, R., Balestrieri, M.L., and D\u2019Onofrio, N. (2024). Sglt2 inhibitor promotes mitochondrial dysfunction and er-phagy in colorectal cancer cells. Cell. Mol. Biol. Lett., 29.","DOI":"10.1186\/s11658-024-00599-1"},{"key":"ref_285","doi-asserted-by":"crossref","unstructured":"Sun, M., Sun, J., Sun, W., Li, X., Wang, Z., Sun, L., and Wang, Y. (2024). Unveiling the anticancer effects of sglt-2i: Mechanisms and therapeutic potential. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1369352"},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1507\/endocrj.EJ15-0396","article-title":"Effect of dapagliflozin on colon cancer cell [rapid communication]","volume":"62","author":"Saito","year":"2015","journal-title":"Endocr. J."},{"key":"ref_287","doi-asserted-by":"crossref","unstructured":"Dutka, M., Bobinski, R., Francuz, T., Garczorz, W., Zimmer, K., Ilczak, T., Cwiertnia, M., and Hajduga, M.B. (2022). Sglt-2 inhibitors in cancer treatment-mechanisms of action and emerging new perspectives. Cancers, 14.","DOI":"10.3390\/cancers14235811"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.molmet.2016.08.014","article-title":"The diabetes medication canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-i supported respiration","volume":"5","author":"Villani","year":"2016","journal-title":"Mol. Metab."},{"key":"ref_289","doi-asserted-by":"crossref","unstructured":"Zhong, J., Sun, P., Xu, N., Liao, M., Xu, C., Ding, Y., Cai, J., Zhang, Y., and Xie, W. (2020). Canagliflozin inhibits p-gp function and early autophagy and improves the sensitivity to the antitumor effect of doxorubicin. Biochem. Pharmacol., 175.","DOI":"10.1016\/j.bcp.2020.113856"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/1878-0261.13508","article-title":"Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (nsclc) through inhibition of hif-1alpha","volume":"17","author":"Biziotis","year":"2023","journal-title":"Mol. Oncol."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"F1041","DOI":"10.1152\/ajprenal.00512.2019","article-title":"Canagliflozin reduces cisplatin uptake and activates akt to protect against cisplatin-induced nephrotoxicity","volume":"318","author":"Song","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"176328","DOI":"10.1016\/j.ejphar.2024.176328","article-title":"Investigation of co-treatment multi-targeting approaches in breast cancer cell lines","volume":"966","author":"Longaray","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"ref_293","doi-asserted-by":"crossref","unstructured":"Akingbesote, N.D., Norman, A., Zhu, W., Halberstam, A.A., Zhang, X., Foldi, J., Lustberg, M.B., and Perry, R.J. (2022). A precision medicine approach to metabolic therapy for breast cancer in mice. Commun. Biol., 5.","DOI":"10.1038\/s42003-022-03422-9"},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"100794","DOI":"10.1016\/j.eclinm.2021.100794","article-title":"Association between cardiovascular risk factors and colorectal cancer: A systematic review and meta-analysis of prospective cohort studies","volume":"34","author":"Zhang","year":"2021","journal-title":"EClinicalMedicine"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41416-020-01143-6","article-title":"Serum lipid profiles and risk of colorectal cancer: A prospective cohort study in the uk biobank","volume":"124","author":"Fang","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_296","first-page":"49","article-title":"Role of dyslipidemia in accelerating inflammation, autoimmunity, and atherosclerosis in systemic lupus erythematosus and other autoimmune diseases","volume":"30","author":"Wang","year":"2020","journal-title":"Discov. Med."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/14737140.2024.2343338","article-title":"Are statins onco- suppressive agents for every type of tumor? A systematic review of literature","volume":"24","author":"Filaferro","year":"2024","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_298","doi-asserted-by":"crossref","unstructured":"Huang, X., Liang, N., Zhang, F., Lin, W., and Ma, W. (2024). Lovastatin-induced mitochondrial oxidative stress leads to the release of mtdna to promote apoptosis by activating cgas-sting pathway in human colorectal cancer cells. Antioxidants, 13.","DOI":"10.3390\/antiox13060679"},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00384-024-04631-w","article-title":"Correlations between preoperative statin treatment with short- and long-term survival following colorectal cancer surgery: A propensity score-matched national cohort study","volume":"39","author":"Loffler","year":"2024","journal-title":"Int. J. Color. Dis."},{"key":"ref_300","first-page":"2223","article-title":"Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells","volume":"5","author":"Agarwal","year":"1999","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1158\/0008-5472.CAN-20-3738","article-title":"Shp2-mediated inhibition of DNA repair contributes to cgas-sting activation and chemotherapeutic sensitivity in colon cancer","volume":"81","author":"Wei","year":"2021","journal-title":"Cancer Res."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"216765","DOI":"10.1016\/j.canlet.2024.216765","article-title":"Lovastatin\/sn38 co-loaded liposomes amplified icb therapeutic effect via remodeling the immunologically-cold colon tumor and synergized stimulation of cgas-sting pathway","volume":"588","author":"Yang","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12935-023-02884-z","article-title":"Statins enhances antitumor effect of oxaliplatin in kras-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy","volume":"23","author":"Tsubaki","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_304","doi-asserted-by":"crossref","unstructured":"Yuan, T., Wu, R., Wang, W., Liu, Y., Kong, W., Yang, B., He, Q., and Zhu, H. (2023). Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1136114"},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"5537737","DOI":"10.1155\/2021\/5537737","article-title":"A novel ruthenium-fluvastatin complex downregulates sncg expression to modulate breast carcinoma cell proliferation and apoptosis via activating the pi3k\/akt\/mtor\/vegf\/mmp9 pathway","volume":"2021","author":"Liang","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"29385","DOI":"10.1021\/acsami.8b11723","article-title":"Loading lovastatin into camptothecin-floxuridine conjugate nanocapsules for enhancing anti-metastatic efficacy of cocktail chemotherapy on triple-negative breast cancer","volume":"10","author":"Zhang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_307","first-page":"1246","article-title":"Synergistic promoting effects of pentoxifylline and simvastatin on the apoptosis of triple-negative mda-mb-231 breast cancer cells","volume":"52","author":"Wu","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41416-021-01529-0","article-title":"Atorvastatin facilitates chemotherapy effects in metastatic triple-negative breast cancer","volume":"125","author":"Marti","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.4143\/crt.2020.1024","article-title":"Combination of simvastatin and fac improves response to neoadjuvant chemotherapy in locally advanced breast cancer","volume":"53","author":"Yulian","year":"2021","journal-title":"Cancer Res. Treat."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.biocel.2012.01.015","article-title":"Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of akt activation and upregulation of timp-1","volume":"44","author":"Chen","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_311","doi-asserted-by":"crossref","unstructured":"Martirosyan, A., Clendening, J.W., Goard, C.A., and Penn, L.Z. (2010). Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: Potential therapeutic relevance. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-103"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2021.12.007","article-title":"Lovastatin enhances chemosensitivity of paclitaxel-resistant prostate cancer cells through inhibition of cyp2c8","volume":"589","author":"Li","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"e2220413120","DOI":"10.1073\/pnas.2220413120","article-title":"Statins enhance the efficacy of her2-targeting radioligand therapy in drug-resistant gastric cancers","volume":"120","author":"Rao","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_314","doi-asserted-by":"crossref","unstructured":"Kitagawa, K., Moriya, K., Kaji, K., Saikawa, S., Sato, S., Nishimura, N., Namisaki, T., Akahane, T., Mitoro, A., and Yoshiji, H. (2020). Atorvastatin augments gemcitabine-mediated anti-cancer effects by inhibiting yes-associated protein in human cholangiocarcinoma cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207588"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/febs.15069","article-title":"Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes","volume":"287","author":"Shojaei","year":"2020","journal-title":"FEBS J."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.toxrep.2020.03.007","article-title":"Time-dependent simvastatin administration enhances doxorubicin toxicity in neuroblastoma","volume":"7","author":"Anderson","year":"2020","journal-title":"Toxicol. Rep."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/bjc.2015.371","article-title":"A randomised, double-blind, placebo-controlled multi-centre phase iii trial of xeliri\/folfiri plus simvastatin for patients with metastatic colorectal cancer","volume":"113","author":"Lim","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1016\/j.ejca.2014.08.005","article-title":"Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study","volume":"50","author":"Kim","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1200\/JCO.2016.69.7391","article-title":"Multicenter, phase iii, randomized, double-blind, placebo-controlled trial of pravastatin added to first-line standard chemotherapy in small-cell lung cancer (lungstar)","volume":"35","author":"Seckl","year":"2017","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2019.04.021","article-title":"Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma","volume":"71","author":"Jouve","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_321","doi-asserted-by":"crossref","unstructured":"Tan, Y., Wang, M., Yang, K., Chi, T., Liao, Z., and Wei, P. (2021). Ppar-alpha modulators as current and potential cancer treatments. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.599995"},{"key":"ref_322","doi-asserted-by":"crossref","unstructured":"Luty, M., Piwowarczyk, K., Labedz-Maslowska, A., Wrobel, T., Szczygiel, M., Catapano, J., Drabik, G., Ryszawy, D., Kedracka-Krok, S., and Madeja, Z. (2019). Fenofibrate augments the sensitivity of drug-resistant prostate cancer cells to docetaxel. Cancers, 11.","DOI":"10.3390\/cancers11010077"},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5114\/aoms.2013.33181","article-title":"Biochemistry of adipose tissue: An endocrine organ","volume":"9","author":"Coelho","year":"2013","journal-title":"Arch. Med. Sci. AMS"},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"e24016","DOI":"10.1590\/s0004-2803.24612024-016","article-title":"Correlation of leptin and adiponectin receptor expression with clinicopathological parameters in colorectal carcinoma\u2014A cross-sectional prospective study","volume":"61","author":"Parmesh","year":"2024","journal-title":"Arq. Gastroenterol."},{"key":"ref_325","doi-asserted-by":"crossref","unstructured":"Taguri, M., Kuchiba, A., Yamaji, T., Sawada, N., Goto, A., Iwasaki, M., and Tsugane, S. (2024). Importance of circulating leptin and adiponectin in the causal pathways between obesity and the development of colorectal cancer in Japanese men. J. Epidemiol., JE20230148.","DOI":"10.2188\/jea.JE20230148"},{"key":"ref_326","doi-asserted-by":"crossref","unstructured":"Greco, M., De Santo, M., Comande, A., Belsito, E.L., Ando, S., Liguori, A., and Leggio, A. (2021). Leptin-activity modulators and their potential pharmaceutical applications. Biomolecules, 11.","DOI":"10.3390\/biom11071045"},{"key":"ref_327","first-page":"438","article-title":"Associations between polymorphisms in leptin and leptin receptor genes and colorectal cancer survival","volume":"20","author":"Du","year":"2023","journal-title":"Cancer Biol. Med."},{"key":"ref_328","doi-asserted-by":"crossref","unstructured":"Chun, K.A., Kocarnik, J.M., Hardikar, S.S., Robinson, J.R., Berndt, S.I., Chan, A.T., Figueiredo, J.C., Lindor, N.M., Song, M., and Schoen, R.E. (2018). Leptin gene variants and colorectal cancer risk: Sex-specific associations. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206519"},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.18632\/oncotarget.13946","article-title":"Leptin-notch signaling axis is involved in pancreatic cancer progression","volume":"8","author":"Harbuzariu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"18239","DOI":"10.18632\/oncotarget.24435","article-title":"Leptin-notch axis impairs 5-fluorouracil effects on pancreatic cancer","volume":"9","author":"Harbuzariu","year":"2018","journal-title":"Oncotarget"},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5306\/wjco.v10.i6.222","article-title":"Leptin-induced notch and il-1 signaling crosstalk in endometrial adenocarcinoma is associated with invasiveness and chemoresistance","volume":"10","author":"Harbuzariu","year":"2019","journal-title":"World J. Clin. Oncol."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5306\/wjco.v8.i1.54","article-title":"Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer","volume":"8","author":"Harmon","year":"2017","journal-title":"World J. Clin. Oncol."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/gut.2008.159293","article-title":"Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition","volume":"57","author":"Fujisawa","year":"2008","journal-title":"Gut"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.3748\/wjg.15.4278","article-title":"Sirolimus, bevacizumab, 5-fluorouracil and irinotecan for advanced colorectal cancer: A pilot study","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1158\/1078-0432.CCR-08-3007","article-title":"Concurrent and sequential administration of chemotherapy and the mammalian target of rapamycin inhibitor temsirolimus in human cancer cells and xenografts","volume":"15","author":"Fung","year":"2009","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4137\/BCBCR.S10071","article-title":"Combining mtor inhibitors with chemotherapy and other targeted therapies in advanced breast cancer: Rationale, clinical experience, and future directions","volume":"7","author":"Yardley","year":"2013","journal-title":"Breast Cancer Basic Clin. Res."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.breast.2020.04.004","article-title":"Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers","volume":"52","author":"Yi","year":"2020","journal-title":"Breast"},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1109653","article-title":"Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1200\/JCO.21.02179","article-title":"Everolimus added to adjuvant endocrine therapy in patients with high-risk hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer","volume":"40","author":"Bachelot","year":"2022","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_340","doi-asserted-by":"crossref","unstructured":"Bernard, S., Poon, A.C., Tam, P.M., and Mutsaers, A.J. (2021). Investigation of the effects of mtor inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells. BMC Vet. Res., 17.","DOI":"10.1186\/s12917-021-03089-0"},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cell.2004.12.040","article-title":"The mtor inhibitor rad001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation","volume":"120","author":"Beuvink","year":"2005","journal-title":"Cell"},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.biopha.2012.11.007","article-title":"Everolimus combined with cisplatin has a potential role in treatment of urothelial bladder cancer","volume":"67","author":"Palmeira","year":"2013","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"41.e11","DOI":"10.1016\/j.urolonc.2013.04.012","article-title":"Temsirolimus improves cytotoxic efficacy of cisplatin and gemcitabine against urinary bladder cancer cell lines","volume":"32","author":"Ferreira","year":"2014","journal-title":"Urol. Oncol."},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"216020","DOI":"10.1016\/j.canlet.2022.216020","article-title":"Mtor inhibitor, gemcitabine and pd-l1 antibody blockade combination therapy suppresses pancreatic cancer progression via metabolic reprogramming and immune microenvironment remodeling in trp53(flox\/+)lsl-kras(g12d\/+)pdx-1-cre murine models","volume":"554","author":"Qiu","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4161\/cbt.7.9.6416","article-title":"Everolimus (rad001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo","volume":"7","author":"Cejka","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"ref_346","first-page":"3801","article-title":"Mtor inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo","volume":"28","author":"Cejka","year":"2008","journal-title":"Anticancer Res."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.2147\/IJN.S204221","article-title":"Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in rcc","volume":"14","author":"Pal","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/sj.bjc.6604995","article-title":"Activity of a novel, dual pi3-kinase\/mtor inhibitor nvp-bez235 against primary human pancreatic cancers grown as orthotopic xenografts","volume":"100","author":"Cao","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_349","doi-asserted-by":"crossref","unstructured":"Lin, S.F., Huang, Y.Y., Lin, J.D., Chou, T.C., Hsueh, C., and Wong, R.J. (2012). Utility of a pi3k\/mtor inhibitor (nvp-bez235) for thyroid cancer therapy. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046726"},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s13046-019-1282-0","article-title":"The dual pi3k\/mtor inhibitor bez235 restricts the growth of lung cancer tumors regardless of egfr status, as a potent accompanist in combined therapeutic regimens","volume":"38","author":"Wu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"ref_351","doi-asserted-by":"crossref","unstructured":"Zhong, Z., Wang, T., Zang, R., Zang, Y., Feng, Y., Yan, S., Geng, C., Zhu, N., and Wang, Q. (2024). Dual pi3k\/mtor inhibitor pf-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-fu. Biomed. Pharmacother. Biomed. Pharmacother., 170.","DOI":"10.1016\/j.biopha.2023.116086"},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1080\/15548627.2022.2160565","article-title":"Dbi\/acbp is a targetable autophagy checkpoint involved in aging and cardiovascular disease","volume":"19","author":"Montegut","year":"2023","journal-title":"Autophagy"},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"312","DOI":"10.15698\/cst2019.10.200","article-title":"Acyl-coa-binding protein (acbp): The elusive \u2018hunger factor\u2019 linking autophagy to food intake","volume":"3","author":"Pedro","year":"2019","journal-title":"Cell Stress"},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.tem.2021.08.009","article-title":"From benzodiazepines to fatty acids and beyond: Revisiting the role of acbp\/dbi","volume":"32","author":"Alquier","year":"2021","journal-title":"Trends Endocrinol. Metab. TEM"},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"e13910","DOI":"10.1111\/acel.13910","article-title":"Acyl coenzyme a binding protein (acbp): An aging- and disease-relevant \u201cautophagy checkpoint\u201d","volume":"22","author":"Montegut","year":"2023","journal-title":"Aging Cell"},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41419-021-03864-9","article-title":"Effects of acyl-coenzyme a binding protein (acbp)\/diazepam-binding inhibitor (dbi) on body mass index","volume":"12","author":"Joseph","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.cmet.2019.07.010","article-title":"Acyl-coa-binding protein is a lipogenic factor that triggers food intake and obesity","volume":"30","author":"Sica","year":"2019","journal-title":"Cell Metab."},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"e2207344119","DOI":"10.1073\/pnas.2207344119","article-title":"Acbp\/dbi protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis","volume":"119","author":"Motino","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41419-024-06633-6","article-title":"Inhibition of acyl-coa binding protein (acbp) by means of a gaba(a)rgamma2-derived peptide","volume":"15","author":"Anagnostopoulos","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41419-022-04834-5","article-title":"An obesogenic feedforward loop involving ppargamma, acyl-coa binding protein and gaba(a) receptor","volume":"13","author":"Anagnostopoulos","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cmet.2019.04.004","article-title":"Acyl-coa-binding protein drives glioblastoma tumorigenesis by sustaining fatty acid oxidation","volume":"30","author":"Duman","year":"2019","journal-title":"Cell Metab."},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41419-023-05813-0","article-title":"Targeting fatty acid oxidation via acyl-coa binding protein hinders glioblastoma invasion","volume":"14","author":"Duman","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_363","doi-asserted-by":"crossref","unstructured":"Yao, J., Liu, Y., Yang, J., Li, M., Li, S., Zhang, B., Yang, R., Zhang, Y., Cui, X., and Feng, C. (2022). Single-cell sequencing reveals that dbi is the key gene and potential therapeutic target in quiescent bladder cancer stem cells. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.904536"},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"106320","DOI":"10.1016\/j.isci.2023.106320","article-title":"Identification of actionable targets for breast cancer intervention using a diversity outbred mouse model","volume":"26","author":"Jacob","year":"2023","journal-title":"iScience"},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1158\/1940-6207.CAPR-14-0057","article-title":"Acyl-coenzyme a-binding protein regulates beta-oxidation required for growth and survival of non-small cell lung cancer","volume":"7","author":"Harris","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"ref_366","doi-asserted-by":"crossref","unstructured":"Cavalloni, G., Peraldo-Neia, C., Massa, A., Bergamini, C., Trentini, A., De Rosa, G., Daniele, L., Ciccosanti, F., Cervellati, C., and Leone, F. (2021). Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in italian intrahepatic cholangiocarcinoma patients. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08576-z"},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0167-0115(98)00013-5","article-title":"Diazepam binding inhibitor and total cholesterol plasma levels in cirrhosis and hepatocellular carcinoma","volume":"74","author":"Venturini","year":"1998","journal-title":"Regul. Pept."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"13530","DOI":"10.18632\/oncotarget.24418","article-title":"Quantitative mass spectrometry analysis reveals a panel of nine proteins as diagnostic markers for colon adenocarcinomas","volume":"9","author":"Atak","year":"2018","journal-title":"Oncotarget"},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11745-997-0073-5","article-title":"Expression of fatty acyl-coa binding proteins in colon cells: Response to butyrate and transformation","volume":"32","author":"Gossett","year":"1997","journal-title":"Lipids"},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.3390\/ijerph110504745","article-title":"Microorganisms with claimed probiotic properties: An overview of recent literature","volume":"11","author":"Fijan","year":"2014","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2036.2007.03442.x","article-title":"Review article: Yeast as probiotics\u2014Saccharomyces boulardii","volume":"26","author":"Czerucka","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jfda.2018.12.011","article-title":"Next generation probiotics in disease amelioration","volume":"27","author":"Chang","year":"2019","journal-title":"J. Food Drug Anal."},{"key":"ref_373","doi-asserted-by":"crossref","unstructured":"Seo, M.J., Won, S.M., Kwon, M.J., Song, J.H., Lee, E.B., Cho, J.H., Park, K.W., and Yoon, J.H. (2023). Screening of lactic acid bacteria with anti-adipogenic effect and potential probiotic properties from grains. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-36961-0"},{"key":"ref_374","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijfoodmicro.2008.09.010","article-title":"The influence of lactobacillus rhamnosus lc705 together with propionibacterium freudenreichii ssp. Shermanii js on potentially carcinogenic bacterial activity in human colon","volume":"128","author":"Hatakka","year":"2008","journal-title":"Int. J. Food Microbiol."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The international scientific association of probiotics and prebiotics (isapp) consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_376","doi-asserted-by":"crossref","unstructured":"Qamar, T.R., Iqbal, S., Syed, F., Nasir, M., Rehman, H., Iqbal, M.A., and Liu, R.H. (2017). Impact of novel prebiotic galacto-oligosaccharides on various biomarkers of colorectal cancer in wister rats. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18091785"},{"key":"ref_377","doi-asserted-by":"crossref","unstructured":"Qamar, T.R., Syed, F., Nasir, M., Rehman, H., Zahid, M.N., Liu, R.H., and Iqbal, S. (2016). Novel combination of prebiotics galacto-oligosaccharides and inulin-inhibited aberrant crypt foci formation and biomarkers of colon cancer in wistar rats. Nutrients, 8.","DOI":"10.3390\/nu8080465"},{"key":"ref_378","doi-asserted-by":"crossref","unstructured":"Kim, C.E., Yoon, L.S., Michels, K.B., Tranfield, W., Jacobs, J.P., and May, F.P. (2022). The impact of prebiotic, probiotic, and synbiotic supplements and yogurt consumption on the risk of colorectal neoplasia among adults: A systematic review. Nutrients, 14.","DOI":"10.3390\/nu14224937"},{"key":"ref_379","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1207\/S15327914NC441_2","article-title":"Foods as risk factors for colorectal adenomas: A case-control study in burgundy (france)","volume":"44","author":"Senesse","year":"2002","journal-title":"Nutr. Cancer"},{"key":"ref_380","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/ajcn\/nqaa244","article-title":"Yogurt consumption and colorectal cancer incidence and mortality in the nurses\u2019 health study and the health professionals follow-up study","volume":"112","author":"Michels","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1002\/ijc.26193","article-title":"Yogurt consumption and risk of colorectal cancer in the italian european prospective investigation into cancer and nutrition cohort","volume":"129","author":"Pala","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_382","doi-asserted-by":"crossref","unstructured":"Murphy, N., Norat, T., Ferrari, P., Jenab, M., Bueno-de-Mesquita, B., Skeie, G., Olsen, A., Tjonneland, A., Dahm, C.C., and Overvad, K. (2013). Consumption of dairy products and colorectal cancer in the european prospective investigation into cancer and nutrition (epic). PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072715"},{"key":"ref_383","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/jn\/135.5.996","article-title":"A synbiotic combination of resistant starch and bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon","volume":"135","author":"Brown","year":"2005","journal-title":"J. Nutr."},{"key":"ref_384","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/carcin\/bgp197","article-title":"Synbiotic intervention of bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats","volume":"31","author":"Hu","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_385","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/carcin\/23.11.1953","article-title":"Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics lactobacillus rhamnosus and bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats","volume":"23","author":"Femia","year":"2002","journal-title":"Carcinogenesis"},{"key":"ref_386","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/ajcn\/85.2.488","article-title":"Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients","volume":"85","author":"Rafter","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_387","first-page":"131","article-title":"Microbiome modulation in the prevention and management of colorectal cancer: A systematic review of clinical interventions","volume":"96","author":"Fratila","year":"2023","journal-title":"Med. Pharm. Rep."},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3748\/wjg.v21.i1.102","article-title":"Fecal microbiota transplantation broadening its application beyond intestinal disorders","volume":"21","author":"Xu","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_389","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1038\/s41467-023-40439-y","article-title":"Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy","volume":"14","author":"Lang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_390","doi-asserted-by":"crossref","first-page":"107278","DOI":"10.1016\/j.phrs.2024.107278","article-title":"Akkermansia muciniphila-derived pentadecanoic acid enhances oxaliplatin sensitivity in gastric cancer by modulating glycolysis","volume":"206","author":"Xu","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_391","first-page":"210","article-title":"Overcome cancer drug resistance by targeting epigenetic modifications of centrosome","volume":"2","author":"Jia","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"ref_392","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1158\/1535-7163.MCT-16-0588","article-title":"Repositioning fda-approved drugs in combination with epigenetic drugs to reprogram colon cancer epigenome","volume":"16","author":"Raynal","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"ref_393","doi-asserted-by":"crossref","unstructured":"Sharma, A., Vatapalli, R., Abdelfatah, E., Wyatt McMahon, K., Kerner, Z., Guzzetta, A.A., Singh, J., Zahnow, C., Baylin, S.B., and Yerram, S. (2017). Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0176139"},{"key":"ref_394","doi-asserted-by":"crossref","unstructured":"Flis, S., Gnyszka, A., and Flis, K. (2014). DNA methyltransferase inhibitors improve the effect of chemotherapeutic agents in sw48 and ht-29 colorectal cancer cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092305"},{"key":"ref_395","doi-asserted-by":"crossref","unstructured":"Huang, K.C., Ke, T.W., Lai, C.Y., Hong, W.Z., Chang, H.Y., Lee, C.Y., Wu, C.H., Chiang, S.F., Liang, J.A., and Chen, J.Y. (2024). Inhibition of dnmts increases neoantigen-reactive t-cell toxicity against microsatellite-stable colorectal cancer in combination with radiotherapy. Biomed. Pharmacother. Biomed. Pharmacother., 177.","DOI":"10.1016\/j.biopha.2024.116958"},{"key":"ref_396","doi-asserted-by":"crossref","first-page":"1989790","DOI":"10.1080\/2162402X.2021.1989790","article-title":"Dnmt1 constrains ifnbeta-mediated anti-tumor immunity and pd-l1 expression to reduce the efficacy of radiotherapy and immunotherapy","volume":"10","author":"Huang","year":"2021","journal-title":"Oncoimmunology"},{"key":"ref_397","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41591-024-02813-1","article-title":"Combined anti-pd-1, hdac inhibitor and anti-vegf for mss\/pmmr colorectal cancer: A randomized phase 2 trial","volume":"30","author":"Wang","year":"2024","journal-title":"Nat. Med."},{"key":"ref_398","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jpha.2023.06.005","article-title":"Histone deacetylase inhibitor pracinostat suppresses colorectal cancer by inducing cdk5-drp1 signaling-mediated peripheral mitofission","volume":"13","author":"Liang","year":"2023","journal-title":"J. Pharm. Anal."},{"key":"ref_399","doi-asserted-by":"crossref","unstructured":"D\u2019Angelo, S., Motti, M.L., and Meccariello, R. (2020). Omega-3 and omega-6 polyunsaturated fatty acids, obesity and cancer. Nutrients, 12.","DOI":"10.3390\/nu12092751"},{"key":"ref_400","doi-asserted-by":"crossref","unstructured":"Cholewski, M., Tomczykowa, M., and Tomczyk, M. (2018). A comprehensive review of chemistry, sources and bioavailability of omega-3 fatty acids. Nutrients, 10.","DOI":"10.3390\/nu10111662"},{"key":"ref_401","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20070456","article-title":"Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism","volume":"116","author":"Flachs","year":"2009","journal-title":"Clin. Sci."},{"key":"ref_402","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3945\/an.111.000505","article-title":"(n-3) fatty acids alleviate adipose tissue inflammation and insulin resistance: Mechanistic insights","volume":"2","author":"Kalupahana","year":"2011","journal-title":"Adv. Nutr."},{"key":"ref_403","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/jama.295.6.655","article-title":"Low-fat dietary pattern and risk of cardiovascular disease: The women\u2019s health initiative randomized controlled dietary modification trial","volume":"295","author":"Howard","year":"2006","journal-title":"JAMA"},{"key":"ref_404","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/ijc.27740","article-title":"Italian mediterranean index and risk of colorectal cancer in the italian section of the epic cohort","volume":"132","author":"Agnoli","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_405","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/ije\/dyx155","article-title":"The mediterranean diet and risk of colorectal cancer in the uk women\u2019s cohort study","volume":"46","author":"Jones","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"ref_406","first-page":"223","article-title":"Mediterranean diet and colorectal adenomas: A systematic review and meta-analysis of observational studies","volume":"33","author":"Clark","year":"2024","journal-title":"Eur. J. Cancer Prev. Off. J. Eur. Cancer Prev. Organ."},{"key":"ref_407","doi-asserted-by":"crossref","first-page":"9851","DOI":"10.18632\/oncotarget.2453","article-title":"Prevention of diabetes-promoted colorectal cancer by (n-3) polyunsaturated fatty acids and (n-3) pufa mimetic","volume":"5","author":"Hertz","year":"2014","journal-title":"Oncotarget"},{"key":"ref_408","first-page":"364040","article-title":"Why and how meet n-3 pufa dietary recommendations?","volume":"2011","author":"Legry","year":"2011","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_409","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3945\/ajcn.2009.29058","article-title":"Diet-dependent acid load, paleolithic [corrected] nutrition, and evolutionary health promotion","volume":"91","author":"Eaton","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_410","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2217\/fon.11.145","article-title":"Curcumin molecular targets in obesity and obesity-related cancers","volume":"8","author":"Shehzad","year":"2012","journal-title":"Future Oncol."},{"key":"ref_411","first-page":"3185","article-title":"Curcumin inhibits proliferation of colorectal carcinoma by modulating akt\/mtor signaling","volume":"29","author":"Johnson","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_412","doi-asserted-by":"crossref","unstructured":"Dou, H., Shen, R., Tao, J., Huang, L., Shi, H., Chen, H., Wang, Y., and Wang, T. (2017). Curcumin suppresses the colon cancer proliferation by inhibiting wnt\/beta-catenin pathways via mir-130a. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00877"},{"key":"ref_413","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2007.03.005","article-title":"Curcumin for chemoprevention of colon cancer","volume":"255","author":"Johnson","year":"2007","journal-title":"Cancer Lett."},{"key":"ref_414","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.1021\/acs.jafc.7b02648","article-title":"Curcumin and salsalate suppresses colonic inflammation and procarcinogenic signaling in high-fat-fed, azoxymethane-treated mice","volume":"65","author":"Wu","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"ref_415","doi-asserted-by":"crossref","first-page":"e1801097","DOI":"10.1002\/mnfr.201801097","article-title":"The combination of curcumin and salsalate is superior to either agent alone in suppressing pro-cancerous molecular pathways and colorectal tumorigenesis in obese mice","volume":"63","author":"Wu","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_416","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1158\/1940-6207.CAPR-10-0098","article-title":"Phase iia clinical trial of curcumin for the prevention of colorectal neoplasia","volume":"4","author":"Carroll","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_417","doi-asserted-by":"crossref","unstructured":"Moetlediwa, M.T., Ramashia, R., Pheiffer, C., Titinchi, S.J.J., Mazibuko-Mbeje, S.E., and Jack, B.U. (2023). Therapeutic effects of curcumin derivatives against obesity and associated metabolic complications: A review of in vitro and in vivo studies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241814366"},{"key":"ref_418","doi-asserted-by":"crossref","unstructured":"Vanamala, J., Reddivari, L., Radhakrishnan, S., and Tarver, C. (2010). Resveratrol suppresses igf-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of igf-1r\/wnt and activation of p53 signaling pathways. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-238"},{"key":"ref_419","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1477-5956-9-49","article-title":"Resveratrol suppresses human colon cancer cell proliferation and induces apoptosis via targeting the pentose phosphate and the talin-fak signaling pathways-a proteomic approach","volume":"9","author":"Vanamala","year":"2011","journal-title":"Proteome Sci."},{"key":"ref_420","doi-asserted-by":"crossref","unstructured":"Ji, Q., Liu, X., Fu, X., Zhang, L., Sui, H., Zhou, L., Sun, J., Cai, J., Qin, J., and Ren, J. (2013). Resveratrol inhibits invasion and metastasis of colorectal cancer cells via malat1 mediated wnt\/beta-catenin signal pathway. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0078700"},{"key":"ref_421","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/1940-6207.CAPR-08-0045","article-title":"(-)-epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male c57bl\/ksj-db\/db mice","volume":"1","author":"Shimizu","year":"2008","journal-title":"Cancer Prev. Res."},{"key":"ref_422","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/ejcn.2014.143","article-title":"The anti-obesity effects of green tea in human intervention and basic molecular studies","volume":"68","author":"Huang","year":"2014","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_423","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.yexcr.2014.01.024","article-title":"Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate","volume":"324","author":"Saldanha","year":"2014","journal-title":"Exp. Cell Res."},{"key":"ref_424","doi-asserted-by":"crossref","unstructured":"Kwon, O.S., Jung, J.H., Shin, E.A., Park, J.E., Park, W.Y., and Kim, S.H. (2020). Epigallocatechin-3-gallate induces apoptosis as a trail sensitizer via activation of caspase 8 and death receptor 5 in human colon cancer cells. Biomedicines, 8.","DOI":"10.3390\/biomedicines8040084"},{"key":"ref_425","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cbi.2009.11.002","article-title":"Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male c57bl\/ksj-db\/db mice","volume":"183","author":"Miyamoto","year":"2010","journal-title":"Chem.-Biol. Interact."},{"key":"ref_426","doi-asserted-by":"crossref","unstructured":"Benito, I., Encio, I.J., Milagro, F.I., Alfaro, M., Martinez-Penuela, A., Barajas, M., and Marzo, F. (2021). Microencapsulated bifidobacterium bifidum and lactobacillus gasseri in combination with quercetin inhibit colorectal cancer development in apc(min\/+) mice. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094906"},{"key":"ref_427","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/ajcn\/nqac012","article-title":"Dietary polyphenols and the risk of colorectal cancer in the prospective southern community cohort study","volume":"115","author":"Fike","year":"2022","journal-title":"Am. J. Clin. Nutr."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/8836\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:36:19Z","timestamp":1760110579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/8836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":427,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ijms25168836"],"URL":"https:\/\/doi.org\/10.3390\/ijms25168836","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]}}}